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ABSTRACT

Background: Despite declining mortality in cardiovascular diseases (CVD), racial disparities
between non-Hispanic Blacks (NHB) and to non-Hispanic Whites (NHW) persist. Although the
prevalence of traditional risk factors of CVD such as hypertension, is higher in NHB compared
to NHW, adjusting for this difference does not eliminate the disparity completely. This suggests
other factors might explain the persisting disparities. Thus, the purpose of this dissertation is to
quantify the impact of chronic stress in explaining the racial disparities in cardiovascular
diseases (CVD). This dissertation contains three studies that addressed the following Specific
Aims:
Specific aims:
1) To create and assess the reliability of various measures (definitions) of chronic stress and
examine their incremental predictive benefit with incident cardiovascular disease.
2) To quantify the effect of chronic stress in explaining the racial disparities of incident
CVD.
3) To identify chronic stress related metabolites associated with incident CVD
Methods: This dissertation leveraged data from the Heart Strategies Concentrating on Risk
Evaluation (Heart SCORE) study. Heart SCORE is an ongoing, prospective cohort and
community-based study of 2,000 community dwelling males and females, aged 45-75 years in
Pittsburgh, Pennsylvania. Chronic stress was defined by counting the number of times an
individual was exposed to various stressors such as perceived discrimination, financial
difficulties, caregiving, job difficulties, and residing in a neighborhood with high depravity. This
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measure was called the Cumulative Reported Chronic Stressors (CRCS). Chronic stress was also
defined using perceived stress using Cohen’s Perceived stress scale (PSS-4) and allostatic load
(AL). Coronary heart disease- a type of cardiovascular disease- was as a composite outcome
defined as the first occurrence of cardiac death, myocardial infarction or coronary
revascularization. In Aim 1, reliability analyses using Cronbach Alpha, Weighted Kappa and
Spearman correlations were used to assess the reliability of the derived measures of stress. Cox
proportional hazard regression models were subsequently used with each measure of chronic
stress to determine the incremental benefit in risk prediction with cardiovascular risk scores such
as the Framingham risk score (FRS) and pooled cohort equation (PCE) risk score, when
applicable. The increase in C-statistic, likelihood ratio test was used to determine predictive
benefit and the net reclassification among events and non-events were used to provide a
summary measure to quantify this effect. These analyses were repeated among various
demographic subgroups. In Aim 2, marginal structural weighted Cox proportional hazards
regression models were used to calculate the controlled direct effect of Race on CVD and the
percentage of the disparity that would be eliminated. Finally, in Aim 3, multiple logistic and
linear regression models were used to identify stress-related metabolites while controlling for
multiplicity error using false discovery rate. Subsequently, ordinal and Cox proportional hazard
regression models were used to identify stress related metabolites associated with ideal
cardiovascular health and CVD.
Results: Among the 1,825 individuals who met the eligibility criteria in Aim 1, 17.3%, 20.1%,
31.4% of the population were classified as having high chronic stress according to CRCS,
allostatic load and perceived stress, respectively. Allostatic load had the weakest agreement with
the other measures of chronic stress (AL vs PSS, κ =0.02; AL vs CRCS, κ =0.11) while CRCS
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and PSS had a slight agreement (κ =0.2). All measures of chronic stress did not improve CVD
risk prediction in the overall population, however, CRCS improved the risk prediction among
low-income Blacks (p=0.08). The net reclassification was 0.455 and -0.237 among low-income
Blacks with and without CVD, respectively.
In Aim 2, the cumulative incidence of CVD was 5% among the 1,735 individuals who met the
eligibility criteria. This resulted in an incidence rate of 5.07/1,000 individuals/year among nonHispanic Blacks and 4.79/1,000 individuals/year among non-Hispanic Whites (incidence rate
ratio: 1.04 (0.68, 1.59)). However, this was much higher among individuals aged 45 – 55 (4.29
(1.22, 15.06)). Among 1,443 individuals with complete data on all relevant study variables, the
controlled direct effects using CRCS as the mediator were 1.45 (0.70 , 3.01) and 1.39 (0.64, 3)
before and after adjusting for traditional risk factors of CVD. This equated in a 43% and 12.6%
elimination of the racial disparity, respected. The effect of CRCS was largely driven by
perceived discrimination which completely eliminated the disparity after adjusting for traditional
risk factors. However, the effect of CRCS on the racial disparity was partially and completely
attenuated when missing data were imputed before and after adjusting for traditional risk factors
of CVD, respectively. Finally, results from Aim 3 identified 36 metabolites associated with
chronic stress. Of these, 14 were associated with ideal cardiovascular health (ICH) and one was
associated with incident CVD. However, this association was driven by its association with CVD
among non-Hispanic Whites.
Conclusion: In conclusion, chronic stress, defined as a count of exposure to multiple stressors
provided incremental predictive benefit beyond the Framingham risk score (FRS) and pooled
cohort equation (PCE) among low-income Blacks. Chronic stress also plays a modest role as a
mediator in the racial disparities in CVD. Finally, the results from this dissertation suggests other
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biomarkers of chronic stress might exist and these biomarkers could elucidate the physiological
relationship between chronic stress and CVD. All three conclusions need to be validated in a
larger, biracial cohort. Future research should examine the drivers of the disparities and the
impact of stress-related epigenetics in young NHB aged 45 – 55.
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CHAPTER 1
INTRODUCTION

BACKGROUND
Cardiovascular disease (CVD) refers to diseases of the heart and blood vessels including
vascular diseases of the brain 1 . It includes diseases such as coronary heart disease (CHD),
stroke (ischemic and hemorrhagic), rheumatic heart disease, congenital heart disease,
arrhythmias, cardiac myopathies such as heart failure and acute myocarditis, and deep vein
thrombosis (DVT) 1. It remains a leading cause of morbidity and mortality in the US and
globally. In 2015, the WHO estimated 422.7 million people had at least one type of
cardiovascular disease 2.
In the United States, cardiovascular disease affects about 92 million Americans and is
responsible for approximately 836,000 deaths or 33% of mortality in 2017 3. Ischemic heart
disease (IHD) or coronary heart disease (CHD), which is a broad term for various cardiovascular
morbidities such as acute myocardial infarction (MI) and chronic stable angina is the leading
cause of global CVD mortality 2. Coronary heart disease accounts for 44% of CVD mortality 3,
affects 15 million people 4 and was responsible for approximately 360,000 deaths in 2015 3.
Despite the significant burden of CVD and CHD in the population, mortality rates have
declined over the last four decades5. Specifically, the age-adjusted mortality rate of CHD
decreased from 1,034 per 100,000 in 1968 to 327 per 100,000 in 2015 6. Although this represents
a significant decrease in mortality rates, disparities exist in the decline and rate of mortality
1

between non-Hispanic Blacks (NHB) and non-Hispanic Whites (NHW). During the last four
decades, the decline in mortality among NHW was at 2.4% per year compared to 2.2% per year
among NHB. In absolute terms, the mortality rate of CVD among NHB was 396 per 100,000 in
2015 compared to 323 per 100,000 among NHW. The NHB to NHW mortality ratio is greater
than 1 in 27 states in the country, with District of Colombia topping the list with 2.416. These
disparities are reflective of the burden of cardiovascular disease among NHB which place NHB
at higher risk of CVD-related mortality, greater severity of CVD and earlier onset of CVD than
NHW 7.
Inquests into the reasons behind these disparities have persisted for decades. Other
research attributes the difference to a higher prevalence of risk factors for cardiovascular disease
in African Americans such as hypertension, obesity, physical inactivity, and diabetes 8,9. In
addition, socioeconomic factors such as income, health system factors (access to medical care),
perceived racism, and poor neighborhood conditions 4,6,10,11 that disproportionately affect African
Americans, are posited to affect risk factors associated with cardiovascular and sub-clinical
cardiovascular disease.
A plausible mechanism through which these non-biological or system-level risk factors
impact CVD is chronic stress 12–14. While numerous experimental and observational studies
demonstrate an adverse effect of acute stress on cardiovascular disease, chronic stress such as
job-strain with low control, caregiving stress, and social isolation are associated with an increase
in the risk of cardiovascular disease 12,13,15,16. These stressors elicit a physiological response that
possibly influences the development of CHD through constant activation of the hypothalamicpituitary-adrenal axis (HPA) and Sympathetic-Adrenal Medulla (SAM) pathway that results in
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the proliferation of hormones such as the catecholamines and corticotrophin. This constant and
prolonged adaptation to stressors adversely impacts various organs and leads to allostatic load 17.
Allostatic load is characterized by elevated biomarkers indicative of organ dysfunction
across various systems such as cardiovascular, metabolic, inflammatory, and neuroendocrinology
18

. It is associated with numerous health outcomes including mortality 19, functional decline in

the elderly 20, and chronic diseases including heart disease 21. Furthermore, prolonged exposure
to chronic stress elicits an inflammatory response, characterized by an increase of cytokines 22,
that can contribute in the inflammatory process that results in atherosclerosis 23. Last, exposure to
chronic stress evokes a behavioral response associated with the uptake of unhealthy behaviors
such as cigarette smoking, poor diet, and inadequate exercise 24–26.
Therefore, the evidence suggests that exposure to chronic stress elicits a biological and
behavioral response that increases the susceptibility to cardiovascular disease. Given the chronic
social disadvantage of NHB 27,28 it might be important to describe and quantify how chronic
exposure to multiple social risk factors (stressors) and the response to these stressors (perceived
stress and allostatic load) might explain the disparity in CVD outcomes between racial groups.

3

Potential Confounders
Unmodifiable risk factors
• Age
• Sex
• Family history of CVD
Modifiable risk factors
• Hypertension
• Education
• Alcohol
• Diabetes
• Smoking
• Obesity measured using waist circumference
• Physical activity
• Access to medications
o Health insurance coverage

•

Exposure
• Race

Mediators

Metabolomic
Signature

Chronic stress
• Perceived stress
• Allostatic load
• Cumulative chronic stressors
o Perceived
discrimination
o Job strain
o Caregiving stress
o Financial difficulty
o Neighborhood
deprivation
o Social isolation

Figure 1: Proposed relationship between study variables
4

Outcome
Incident Major
Adverse
Cardiovascular
Event (MACE)

PURPOSE OF THE DISSERTATION
The primary purpose of this dissertation is to quantify the role of chronic stress in the
racial disparity of cardiovascular disease. More specifically, this dissertation will determine the
impact of exposure to chronic stressors such as perceived discrimination, financial difficulties,
job stress, caregiving stress or living in a deprived neighborhood on cardiovascular diseases and
perceived stress in explaining the worse outcomes in cardiovascular diseases (CVD) observed
among non-Hispanic Blacks (NHB).
Numerous studies report higher exposure to and perception of chronic stress among NHB
28–30

. Furthermore, numerous studies have reported associations of stress with incident

cardiovascular disease 14,31–35. While studies have been inconsistent in the measurement of stress,
the message is consistent: Stress is an independent risk factor of cardiovascular disease 13.
Therefore, this project is founded on the hypothesis that NHB are exposed to more chronic
stressors across multiple domains (cumulative) compared to other racial groups, including NHW,
and this differential exposure to stressors is a pathway that leads to excess risk of CVD observed
in this population. Accordingly, the following questions emanated from the aforementioned
hypothesis and will be answered across three specific aims of this dissertation:

5

Research Questions
1) Does the inclusion of measures of chronic stress result in an incremental benefit of
predicting incident CVD compared to the Pooled Cohort Equation and Framingham risk
score?
2) Do perceived chronic stress and cumulative exposure to multiple stressors mediate the
excess risk in CVD among NHB
3) Are there metabolomic signatures associated with chronic stress and are these metabolites
associated with CVD?

PUBLIC HEALTH SIGNIFICANCE: CLOSING THE GAP
The difference in life expectancy between NHB and NHW narrowed from 5.9 years in 1991 to
3.6 years in 2013 due to a reduction in mortality from cardiovascular disease, HIV and cancer 36.
Thus, continued effort in improving CVD outcomes among NHB could narrow this gap even
further. Quantifying the role of chronic stress on racial disparities in cardiovascular outcomes
could provide requisite evidence to increase funding for preventive CVD programs that target
social determinants of health (SDoH). Furthermore, the results of this dissertation could provide
compelling evidence to justify the continued inclusion of chronic stress management in the
national prevention guidelines of cardiovascular disease and support efforts for the systematic
collection of social stressors in electronic health records (EHR).

6

CHAPTER 2
LITERATURE REVIEW

CARDIOVASCULAR DISEASES
Cardiovascular disease refers to diseases of the heart and blood vessels. It remains a
leading cause of morbidity and mortality in the US and globally. In 2015, the WHO estimated
422.7 million people have at least one type of cardiovascular disease 2. In the United States,
cardiovascular disease affects about 92 million Americans and is responsible for approximately
836,000 deaths or 33% of mortality in 2017 3. Coronary heart disease (CHD) accounts for 44%
of the total mortality from CVD in the population and will be the primary focus in this
dissertation.

Physiology of Coronary Heart Disease
Coronary heart disease is a disease of the coronary artery and the heart characterized by
stenosis of the coronary arteries due to lipid deposits or atherosclerotic plaques 3. The coronary
artery is the blood vessel that supplies the heart with blood and is made up of three main layers:
the adventitia, media, and the intima 37. All three layers represent the outermost, middle and
innermost layers of the coronary artery, respectively. The intima is essential in the pathogenesis
of coronary artery disease because it’s covered by the endothelium which is supported by the
basement membrane and elastic lamina. The endothelial surface comes in direct contact with
7

blood and is responsible for the production of vasoactive substances such nitric oxide (NO),
tissue plasminogen (tPA) and prostacyclin with potent vasodilatory and anti-thrombogenic
functions 38,39. The endothelial cells also ensure the blood remains liquid and prevents
coagulation through the action of thrombomodulin, heparin and prostacyclin produced in the
endothelium 39. Thus, damage to the endothelium causes an imbalance that could lead to prethrombotic or pro-atherosclerotic changes. This underscores the importance of the vascular
endothelium in the pathogenesis of coronary heart disease.

Atherosclerosis- A precursor to CHD
The pathogenesis of CHD begins with atherosclerosis. Atherosclerosis is a disease
condition that results in the hardening and stiffening of the coronary artery due to accumulation
of cholesterol laden plaques 40. In addition to cholesterol, these plaques contain smooth muscle
cells, calcium, inflammatory cells, and macrophages. The accumulation of these plaques in the
intima of the coronary artery leads to narrowing of the artery, reduced blood supply, increase
oxygen demand and acute coronary syndrome (myocardial infarction and angina) 40,41.
The atherosclerotic process begins with damage to the endothelial surface that increases
vascular permeability, promotes coagulation, and inhibits the production of nitric oxide 41–44.
This damage is believed to be caused by risk factors of atherosclerosis (hypertension, smoking,
and diabetes), inflammation, systemic infection, injury, or non-laminar or turbulent blood flow
40,41

. In response to the inhibition of nitric oxide (NO), proinflammatory cytokines (ex. IL-6) and

adhesion molecules (such as vascular adhesion molecules (VCAM) and p-selectin) recruit
immune cells like monocytes into the endothelial wall which mature into macrophages.
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Macrophages further release cytokines, free O2 radicals, proteases and complement factors that
continue the inflammatory process and lead to further damage to the endothelium.
Hypercholesterolemia promotes the entrapment of low-density lipoproteins (LDL) and
very low-density lipoproteins (VLDL) in the endothelium that leads to their oxidation.
Macrophages engulf these oxidized LDL particles to form foam cells which lead to a fatty streak.
Fatty streaks in the arteries are believed to be indicative of early stages of an atherosclerotic
process 42,44. Macrophages also evoke an inflammatory response through recruitment of smooth
muscle cells from the Media of the vascular endothelia. 23. This entire process ends in the
formation of atherosclerotic plaques. If the plaque is unstable, it can rupture and form an
embolus which can lead to myocardial infarction or stroke. Plaque rupture is primarily
responsible for myocardial infarction than stenosis or narrowing of the arteries 45. Given the
prominent role of local proinflammatory markers in the pathogenesis of atherosclerosis,
researchers view atherosclerosis as a disease of inflammation rather than solely an accumulation
of lipids 41.

Epidemiology of Coronary Heart Disease (CHD)
Coronary heart disease is a disease of the coronary arteries and the heart 1. It includes
conditions such as acute myocardial infarction, unstable angina, and stable angina. It is the
leading cause of mortality from cardiovascular disease in the United States and globally 2.
Despite representing 26% of all cases of cardiovascular disease in the US, coronary heart disease
represents 44 - 45.1% of all CVD related deaths in the US, making it a potent cause of mortality
3,46

. CHD was responsible for 360,000 deaths in 2015, making it the second cause of mortality

behind cancer in the US and a major public health problem 3. A recent study estimated that if all
9

CVD were eliminated, life expectancy in the US would increase by seven years46. It is therefore
plausible that aggressive preventive efforts towards reducing the incidence of CHD could result
in an increased life expectancy in the US.
Through concerted efforts in the medical and public health communities, the mortality
rates from coronary heart disease are declining and have been declining for close to four decades
due to early identification and intervention of individuals at risk of CHD46,47. The risk factors of
coronary heart disease can be divided into two broad categories:
1) Unmodifiable risk factors
2) Modifiable risk factors
Unmodifiable risk factors include age, race/ethnicity, sex at birth, genetics and family
history. Age and sex have long been linked with cardiovascular disease 48,49. Although the
leading cause of mortality among men and women above 65 years of age is CVD; the onset and
severity of disease, however, is dependent on sex. Women are diagnosed with CVD at an age 10
years older than men and extends to 20 years for more severe forms of CVD 46. This difference
is attributed to vasodilatory effect of endogenous estrogens that ultimately confers some
protection against CVD in premenopausal women 50. However, administration of exogenous
estrogen to premenopausal women for the prevention of CHD has been unsuccessful 50. In 2017,
the age-adjusted CHD mortality rates for men and women was 266.1 and 182.1 per 100,000,
respectively 46.
Mounting evidence suggests the epidemiology of coronary heart disease differs by race and
ethnicity. Non-Hispanic Blacks (NHB) have the highest rates in their respective sex groups. The
mortality rates for men by race is 352.4, 267.8, and 192.4 per 100,000 for NHB, NHW, and
Hispanics, respectively. Similarly, the mortality rates are 241.3, 182.1, and 131.7 per 100,000 for
10

NHBs, NHWs and Hispanic women, respectively46. This shows that NHB men have the highest
rate than any sex-race group and NHB women have similar rates to NHW men but significantly
higher rates than NHW women and Hispanic men and women.
Modifiable risk factors for heart disease can be further broken down into two categories:
clinical and non-clinical risk factors. Clinical modifiable risk factors include high blood pressure
(high blood pressure), high low density lipoprotein, remnant cholesterol, diabetes, and adiposity.
Non-clinical modifiable risk factors include physical activity, depression, diet, stress and the
built environment. These risk factors have been discussed extensively in numerous literature and
are established risk factors of CHD. Thus, they will not be the emphasis of this dissertation.

Evidence of Racial Disparities in CVD
Despite national efforts to eliminate racial disparities in cardiovascular disease (CVD),
these disparities persist 9. Non-Hispanic Blacks (NHB) are more likely to be diagnosed with
premature CVD- diagnosed with CHD <55 years of age, have 30% higher mortality rates than
Non-Hispanic Whites (NHW) 7 and twice as likely to die from CVD compared to non-Hispanic
whites 6. These racial disparities are attributed to higher prevalence of traditional risk factors
such as hypertension 51, diabetes, and obesity among African Americans 52,53. The lifetime risk
for developing atherosclerotic-related CVD (ASCVD) also varies by race. Among individuals
aged 40 – 79, 42% of NHB men have more than 10% risk of developing ASCVD compared to
34% of NHW men. Similarly, 27.4% of NHB women compared to 16.7% NHW women have
more than 10% risk of developing ASCVD 54. Cardiovascular health, defined as the presence of
seven health-related factors and behaviors such as blood pressure, cholesterol, hbA1c, BMI,
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physical activity, diet, and smoking, is low among NHB. A 2018 study examined trends in ideal
cardiovascular health among adults age 25 and over and concluded that NHB had the lowest
prevalence of ideal cardiovascular health (15%) compared to Hispanics (25%) and NHWs (40%)
over the 26-year observational period 55.
Racial disparities also exist among specific types of ASCVD. According to the annual
update from the American Heart Association (AHA), the prevalence of coronary heart disease
(CHD) is higher among NHB women compared to NHW women (5.7% vs. 5.1%). Conversely,
NHW men have a higher prevalence of CHD compared to NHB men (7.7% vs. 7.3%). Despite
the differences in prevalence, NHB men and women have higher incidence rates compared to
NHW males and females (6.6 vs.3.8/1000 and 4.3 vs. 2.2/1000, respectively) 46. Complications
from first MI are worse among NHB than NHWs as NHB men and women are two times more
likely to have a recurrent MI compared to NHW counterparts. Moreover, mortality rates from MI
are highest for NHB males (150.6/100,000), followed by NHWs (137.5/100,000) and Hispanic
men (98.4/100,000). Similar trends are observed among females with NHB women having the
highest rates (89.4/100,000) and Hispanic women with the lowest rate (57.2/100,000) 46.
According to the CDC, 4.5% non-Hispanic Blacks reported to be diagnosed with stroke
compared to 2.5% non-Hispanic Whites. NHB were second only to American Indians who had a
reporting prevalence of 5.4% . However, data from 2006 – 2010 Behavioral Risk Factor
Surveillance System (BRFSS) show that the trend in prevalence by NHWs and NHB have
remained relatively constant over time (range: 2.2% - 2.4% for NHWs and 3.7% - 4.1% for
NHBs). Age-adjusted incidence of first occurrence of stroke was higher among NHB compared
to NHW and according to data from the REasons for Geographic and Racial Differences in
Stroke (REGARDS) study, the black-white incidence ratio for stroke peaked at 4.02 among
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individuals 45-55 years 56. Similarly, mortality data shows that NHB have the highest ageadjusted mortality rate from stroke compared to other races, including NHWs. In 2014, 19 more
NHB men died from stroke compared to NHWs men (56.5 per 100,000 vs 35.1 per 100,000) 46
The reasons behind the disparities are mixed but largely center around higher prevalence
of traditional risk factors among NHB compared to NHWs. Among the traditional risk factors,
the higher prevalence of hypertension, diabetes and obesity among NHB appear to have the
strongest evidence. The prevalence of high blood pressure (BP) among NHB men and women is
higher than NHW men and women. Furthermore, NHB get diagnosed with hypertension at a
younger age, are more likely to have non-dipping blood pressure, resistant BP, and higher
ambulatory BP at nighttime compared to NHWs 46. Surprisingly, the prevalence of traditional
risk factors is not always higher among NHBs. For example, the prevalence of smoking is
slightly higher among NHB men compared to NHW men (20.9% vs. 17.2%) but lower among
NHB women compared to NHW women (13.3% vs. 16%) 57. Similarly, NHB have lower total
cholesterol levels (10.5%) compared to NHWs (13%) 58. NHB have better low density
lipoproteins (LDL), high density lipoprotein (HDL) and triglyceride profiles compared to NHWs
46

.
Other explanations such as socioeconomic status and genetics have been suggested but do

not account for the disparities. For example, Williams and Leavell, 2012 reported that NHB had
higher CVD mortality compared to NHWs of similar education level. 7. This suggests that
poverty and measures of SES, although relevant to CVD outcomes, are not primary drivers in
observed racial disparities between NHB and whites. Genetic disposition affects CVD outcomes,
however, it is also unlikely to primarily account for racial disparities in CVD. A study of foreignborn, US-born blacks and NHWs concluded that foreign-born blacks had similar odds of stroke
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to NHWs and lower odds compared to AA 59. If genetics were a major driver, the relative odds
between foreign-born and US-born blacks would be similar.
Given the evidence in the literature, it is apparent the reasons associated with the racial
disparities are multifactorial and beyond traditional risk factors, poverty and genetics. Thus,
discovering additional factors based on empirical evidence is necessary. The ideal putative risk
factor would be more prevalent among NHB and associated with cardiovascular disease.

STRESS IN EPIDEMIOLOGICAL RESEARCH
Definition and Use of Stress in Epidemiological Research
Stress is a broad terminology used to describe the influence of external agents or noxious
agents on the human physiological and biological systems 14,60. It has also been described to
occur whenever the psychosocial resources are insufficient to match the demand of the noxious
agents 61. The definition of stress has slowly evolved over time to differentiate stressors from the
stress response. Stressors refer to the stimuli while the stress response refers to the individual’s
physiological response to the stressor and is dependent on the individual’s perception or
appraisal of the situation as a potential stressor 62.
The biological response to stress or stress response is of interest to the research
community due to its potential etiological role in the pathogenesis of chronic diseases,
specifically coronary heart disease 17,61,63. The stress response is an adaptation of biological
systems to negate effects of copious agents with the intention to restore and maintain
homeostasis- a concept called allostasis 17,21,64. It has been over seven decades since the first
biological response to stress was described in the literature. In his seminal Letter to the Editor
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titled “A Syndrome produced by Diverse Nocuous Agents”, Hans Selye described the biological
response of lab rats to acute exposures such as cold, surgical injury, drugs as a protective effect
to withstand the potential damage of the exposures60. The results from the paper had a
provocative effect on the scientific community and was followed by an interest in the role of
stress and disease. Following the work of Selye, psychiatrists Thomas Holmes and Richard Rahe
who are credited with the creation of the social readjustment rating scale hypothesized that
individuals who experienced more stressful events would require greater biological adaptation
and excessive adaptation may result in poorer health outcomes 65. They confirmed this
hypothesis through empirical evidence that showed naval officers with more life changing
experiences, cumulated over time, were more likely to have adverse health outcomes. Since then
additional research have explored the role of stress in aging 66 and chronic diseases like coronary
heart disease 13, cancer 67, and infection 68.

Types and Measures of Stress
Stress is an ubiquitous word that has been used in the literature to describe the exposure
to obnoxious stimuli (stressors) or response to the stimuli (stress response). The Stress Network
– a nonprofit organization interested in harmonizing measures of stress- summarized domains of
stress and the characteristics of stressors 62. Types of stress domains include:
1) Stressful life events and trauma
2) Financial strain
3) Job strain/stress
4) Discrimination
5) Caregiving stress
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6) Loneliness
7) Environmental/neighborhood stress
As part of a global effort to unify terminologies used in stress research, the Stress Network
summarized characteristics into main four (4) main categories:
1) Timescale: Acute, daily, life events, chronic
2) Life-period: In-utero, Childhood, Adulthood, Lifespan
3) Assessment window: Timeframe
4) Attributes: Life domains the stressor exists in.
These characteristics help in assessing how the stressor operates in association with disease.
Furthermore, stress response can be divided into three categories:
1) Perceived stress: Measure of global response to stressors
2) Behavioral coping: poor diet, smoking, or diminished self-care
3) Physiological response: Allostatic load
Thus, a stressor could have an impact throughout the lifespan of an individual and exposure to
this stressor could result in perceived, behavioral and/or physiological response . This provides a
challenge in the measurement of stress. Numerous published research looking at chronic
stressors and cardiovascular disease have measured stress in one domain. Thus, it would be
important to examine the impact of cumulative exposure to multiple stressors across numerous
domains on cardiovascular disease.
Numerous scientific theories and models are posited to explain the relationship between
adverse social stressors and coronary heart disease. The following briefly introduces the theories
and provide plausible explanations to the mechanism of stress-related health outcomes.
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1) Social cognitive pathway model: Proposed by Jennifer Phillips and Williams Klein in
2010 69, the Social Cognitive Pathway model attempts to explain the mechanism through
which low SES leads to coronary heart disease (CHD). The Social Cognitive Pathway
model assumes that an individual’s perception of themselves and their surroundings may
lead to low perceived self-efficacy, control, impede motivation to seek healthcare and
mediate the association between low SES and CHD. However, the body of evidence that
supports this theory have come from cross-sectional studies which are susceptible to
reverse causality 69. Also, few studies that have explicitly measured mediation have
resulted in null findings.
2) Weathering hypothesis: Based on the premise that African Americans experience
cumulative social disadvantage relative to other racial/ethnic groups which leads to
‘weathering’ 70. The hypothesis was initially postulated to explain the disparities in birth
outcomes between black and white mothers as well as the relative higher prevalence of
teenage pregnancies among AA women compared to NHW women. However, the
hypothesis can be extended to explain accelerated physiological aging among AA and the
higher prevalence of early morbidity in the population 71. The allostatic load for AA is
higher across all ages than NHWs and may support the Weathering hypothesis 71
3) Demand-Control and Effort-Reward imbalance models: These two models are a mainstay
in occupational health and are often used to describe the impact of occupational stress on
adverse health outcomes 72,73. Demand-control postulates that individuals in a high
demanding job with little control or resources to cope with the demands are susceptible to
adverse health outcomes. Similarly, the effort-reward imbalance suggests that individuals
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whose rewards are not commensurate to the effort they put in elicit a stressful reaction
which could in turn lead to adverse health outcomes 74(p).

PHYSIOLOGICAL RESPONSE TO STRESS IN RELATION TO CORONARY HEART
DISEASE
The physiological response to acute stress is well known and characterized. Acute
stressors perpetuate their effect through the activation of the hypothalamic-pituitary-adrenal
(HPA) axis and sympathetic nervous system (SNS). This was tested in humans using the Trier
Social Stress Test (TSST). The use of TSST enabled researchers observe the physiological
response to acute stress under experimental conditions by subjecting participating subjects to
mental tasks and public speaking. Results showed a marked increase in hormones of the HPA
such as adrenocorticotropic hormone (ACTH) and cortisol 75.
Catecholamines are also implicated in the physiological response to acute stressors. In a
recent study, catecholamine-adrenergic receptor complexes were hypothesized to lead to an
increase in clotting factor VIII, fibrinogen, and D-dimer after infusion of norepinephrine that
mimicked an acute stress response to human subjects 76. These findings were supported by the
attenuation of effect upon administration of phentolamine (adrenergic blocker) in the study and
other studies in the literature that have shown thrombotic-stimulatory characteristics of
norepinephrine 77,78. Furthermore, circulating catecholamines suppress the parasympathetic
nervous system leading to a decreased vagal tone and reduced activity by acetylcholine (ACH).
Consequently, acetylcholine suppresses proinflammatory markers and a decrease in
concentration could lead to an increase in proinflammatory markers 79. Therefore, acute stressors
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have the ability to affect CVD through activation of the HPA axis, increase in inflammation and
promotion of coagulation. These processes are known to influence atherosclerosis 41,45,80.
Unlike acute stress, the physiological response to chronic stressors such as work-related
stress or being a caregiver for a loved one with a debilitating condition 61 is less elucidated.
Chronic stressors have been postulated to exert their impact by repeated activation of the
hypothalamic-pituitary-adrenal axis (HPA) and the sympathetic nervous system 81; ultimately
resulting in allostatic load.
The hypothalamic-pituitary-adrenal axis is anatomically located in the central nervous
system (CNS, i.e. hypothalamus and pituitary glands) and peripheral nervous system (PNS, i.e.
adrenal glands). The principal role of the hypothalamus is to regulate homeostasis through the
secretion of hormonal releasing factors that act on the pituitary gland which in turn produces
hormones that affect biological organs in the peripheral nervous system.
Specifically, in response to stress, the hypothalamus secretes the corticotrophin releasing
factor (CRF) which subsequently binds to its receptors in the anterior pituitary gland. The
binding of the CRF leads to the production and release of adrenocorticotropic hormone (ACTH)
into the blood. The hormone is absorbed by the zona fasciculata of the adrenal cortex in the
adrenal gland which consequently causes the release of glucocorticoids into the blood. An
important example of a glucocorticoid is cortisol. Excessive concentrations of glucocorticoids
leads to the inactivation of the HPA axis through a negative feedback mechanism 82.
Glucocorticoids such as cortisol are a general name for hormonal steroids produced in the
adrenal cortex that are involved in the production of glucose (gluconeogenesis), possess antiinflammatory actions and regulate metabolism 83. Thus, they are essential for the regulation of
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key biological processes and protect the body from the harmful effects of stress. However,
cortisol has a direct effect on the cardiovascular system by increasing sensitivity to circulating
catecholamines. It also leads to lipolysis which could lead to an increase in circulating blood
cholesterol. Thus, the continuous and excessive stimulation of the HPA axis can lead to the
excessive production of cortisol which in turn could lead to the development of chronic diseases
such as hypertension heart disease and diabetes 84–86.
Chronic stressors also elicit an inflammatory response by inducing cytokine production.
These stress-induced cytokines stimulate expression of adhesion molecules like vascular cellular
adhesion molecule (VCAM) in the intima of the artery, promote chemotaxis of leucocytes and
monocytes into an atherogenic artery and increase the translocation of low-density lipoprotein
into the arterial wall by increasing the expression of LDL receptors on endothelial cells in the
artery 87. These processes are crucial steps in the development of atherosclerosis, which is a
causal risk factor of coronary heart disease. Cortisol is also implicated in the inflammatory
process. This might sound counterintuitive for cortisol which has potent anti-inflammatory
actions, however, preliminary evidence suggests cortisol promotes inflammation and
inflammatory processes88. As described earlier, chronic stressors lead to repeated activation of
the HPA which leads to prolonged secretion of cortisol. This could lead to downregulation of
cortisol receptors leading to diminished anti-inflammatory action and potential increased
inflammation. Also, increased secretion of cortisol may result in greater affinity for
mineralocorticoid receptors which have proinflammatory actions 89. Atherosclerosis- a causal
risk factor of CHD- is a disease of inflammation.
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EPIDEMIOLOGICAL EVIDENCE OF CHRONIC STRESS AS RISK FACTOR FOR
CHD
The association between chronic stress and cardiovascular disease- especially coronary
heart disease- has long been described in the literature. Numerous research have described the
association between measures or correlates of stress and CHD using cross-sectional and
prospective study designs.
The role of stress in CHD is complex and multifactorial 23,61. Stress can have a direct
effect in the pathogenesis of CHD by damaging the endothelium of the blood vessel. It could
also have an indirect effect by promoting risk factors of CHD such as smoking and poor diet.
The next few paragraphs will describe the major findings of the association between stress and
MI in the literature and explore the potential mechanisms involved.
Chronic exposure to stress is measured in the literature using various measures such as
work-related stress. Work-related stress has been defined as monotonous work, or jobs with high
demand but low control (job strain) and low social support. These definitions are based off three
models namely: job-strain model, effort and reward model, and organizational injustice model 90.
A recent meta-analysis conducted by Kivimaki et al90 summarized the association between workrelated stress and CHD using data from 14 prospective cohort studies. They concluded that
work-related stress from organizational injustice contributed to approximately 50% excess risk
of CHD among employees who experienced it (RR=1.47, 95% CI=1.12-1.95) 90. Work-related
stress from job strain and high effort with low rewards lost statistical significance after
controlling for multiple risk factors. However, other research has shown mixed results between
the association between job strain and coronary heart disease. Job strain did not lead to an
increase the risk of CHD in a few studies 91–93 after controlling for potential confounders.
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However, one cross-sectional study 94 and prospective cohort study 95 found associations
between job strain and CHD. The prospective cohort study found an association between lowcontrol at work and any CHD for men (HR: 1.43, 95% CI=1.15-1.78) but not women. When the
data were restricted to non-fatal MI in the prospective cohort study, the association was
attenuated and became non-statistically significant after controlling for other risk factors (HR:
1.30 95% CI=0.93-1.90).
Other measures of chronic stress such as marital stress, caregiving, and social isolation
are associated with CHD. Marital stress in females- defined using the Stockholm marital stress
scale (SMSS)- was determined to be a prognostic risk factor in the recurrence of acute
myocardial infarction among a cohort of 279 Swedish females who were working or living
together with a male partner 96. The effect of marital stress resulted in a hazard ratio of 2.9 (95%
CI 1.3-6.5). Lee at al studied the impact of taking care of a terminally ill spouse or parent as a
proxy for psychosocial stress on incident CHD using data from the Nurses’ Health Study 97.
CHD was defined as first MI or death from heart disease and results showed that women who
spent at least 9 hours a week looking after a spouse were more likely to develop incident CHD
(HR=1.82, 95% CI 1.08-3.05). A null association was found between caregiving for a parent and
incident CHD. Social isolation and loneliness have been studied as proxies of chronic stress. A
meta-analysis of prospective cohort studies in populations without prevalent CHD showed 50%
increase in risk between social isolation and loneliness and incident CHD (RR=1.5; 95% CI=
1.2-1.9) 13.
The largest study till date that examined the association between stress and myocardial
infarction is the INTERHEART study. The INTERHEART study was a global case-control
study that investigated the risk factors of myocardial infarction using data from 29,972 study
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participants (12,461 cases and 14,637 controls were used in the final analysis) from 52 countries
in each continent 98. Psychosocial factors, as a proxy for chronic stress were measured. A
composite psychosocial index was derived by including subjects with work or home related
stress, depression, major life events, and low control. The odds ratio of subjects with at least one
psychosocial factor compared to subjects with none was 2.67 (99% CI: 2.21-3.22) after
controlling for traditional risk factors. This represented a population attributable risk (PAR) of
32% in the population studied. Other examples include results from the Coronary Artery Risk
Development in Young Adults (CARDIA) study which showed that work-related stress was
associated with incident hypertension; a strong risk factor for acute myocardial infarction 99.
Other studies have operationalized the concept of job-strain differently but found similar
findings100,101.
Therefore, the impact of chronic stressors on CHD could be largely mediated by a
behavioral response that promotes the incidence of traditional risk factors (diabetes, metabolic
syndrome, and hypertension). However, stress might have a small direct effect on CHD by
participating in the inflammatory process of atherosclerosis.
EVIDENCE OF RACIAL DISPARITIES IN EXPOSURE TO CHRONIC STRESSORS
African-Americans (AA) or Non-Hispanic Blacks are differentially exposed to economic,
cultural and psychological stressors than other racial and ethnic groups in the US 7,102–104. A
study by Utsey and colleagues demonstrated a higher level of racism-related stress among
African Americans compared to other ethnic groups and explained 16% of the variance
associated of poor quality of life associated with racism-related stress 29. The higher prevalence
of these stressors among African Americans has been associated with poorer health outcomes.
For example, a recent study conducted by investigators from the Jackson Heart study concluded
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that individuals with moderate to high levels of financial stress had more than a two-fold
increase in risk of incident coronary heart disease compared to individuals with low financial
stress. This association was independent of traditional clinical risk factors of CHD, age,
demographics and SES 105.
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CHAPTER 3
SPECIFIC AIM 1

INTRODUCTION
Numerous studies link chronic stress with chronic diseases such as cardiovascular disease
(CVD). Chronic stress is associated with risk factors of cardiovascular health 34,106,107, and
cardiovascular outcomes like coronary heart disease (CHD) and stroke 13,108. Despite the
preponderance of evidence linking stress to CVD, the clinical utility of chronic stress in
prognostic risk equations (RE) such as Framingham or Pooled Cohort risk equation remains
unknown. This is especially important for African Americans who are differentially exposed to
chronic stress and have worse CVD outcomes.
A possible reason could be the absence of a standardized, agreed upon measure of stress
that adequately captures the chronicity and multidimensionality of stress. In her recent article,
Epel et al advocated for the distinction between stressors and stress response when assessing the
impact of stress on health 62. This approach enables researchers to adequately assess which
stressors are linked to the outcome of interest. Researchers use a variety of measures of stressors
when examining chronic stress and CVD. For example, Steptoe and Kivimaki published a metaanalysis summarizing the evidence that established job strain and social isolation/loneliness as
risk factors of CVD in a non-US population 109. Within the United States, frequently studied
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stressors on CVD include perceived discrimination 33,110,111 and disadvantaged neighborhoods
112,113

. These domains are frequently measured individually. Similarly, the response to stress is

measured using hormones of the hypothalamic-pituitary adrenal (HPA) axis (such as cortisol,
epinephrine and norepinephrine) and allostatic load. Perceived stress- a perception of lack of
control over events happening in a person’s life- is frequently examined with CVD 106,114.
However, studies examining the effect of multiple stressors across multiple domains are rare.
This is surprising given the viable plausibility of exposure to multiple chronic stressors
over the life course of an individual. A recent study by Burroughs et al examined the impact of
cumulative psychosocial stressors, including acute stressors on ideal cardiovascular health, in
25,062 older women concluded that black women had a 10-point higher cumulative stress score
and worse ideal cardiovascular health (ICH)- a construct that confers protection from future
CVD- compared to white women 107. This difference in cumulative stress score also responsible
for differences in ICH score by approximately 12.7%. However, the study was cross-sectional
with a very low percentage of black women (1.76%). Another study found people with high
chronic stress were less likely to achieve ideal cardiovascular health specifically due to high
prevalence of smoking and fasting blood glucose 106.
Currently, there is a gap in the literature in assessing measures of chronic stress across
multiple domains and CHD outcomes. Also, it is unknown whether these measures of stress have
clinical utility in predicting future CHD events.
Therefore the objectives of this specific aim are as follows:
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1) Create three measures of chronic stress according to the response to stress (Perceived
Stress Score and Allostatic load) and exposure to the stressful stimuli (Cumulative
Reported Chronic Stressors (CRCS))
2) Assess the relationship between measures of chronic stress using Spearman Correlations
and weighted Kappa
3) Determine the incremental net benefit of including measures of chronic stress in risk
prediction models for incident CHD.

METHODS
Recruitment and Data source
This project utilized extant data from the Heart Strategies Concentrating on Risk
Evaluation (Heart SCORE) study. Heart SCORE is an ongoing prospective cohort and
community-based study of 2,000 community dwelling individuals aged 45-75 years in
Pittsburgh, Pennsylvania. The primary goal of the Heart SCORE study is to identify mechanisms
that explain population differences in cardiovascular disease outcomes for the purposes of
eliminating racial disparities in CVD 115. Thus, the Heart SCORE population contains higher
than average representation of African American participants (43%).
Recruitment of study participants began in 2003 and involved direct mailing of
questionnaires, community and physician referrals, print and electronic media, and public service
announcements. Data were collected at baseline and during annual follow-up visits on
characteristics such as sociodemographic, clinical markers, medical history, psychosocial risk
factors (depression, hostility, anger, anxiety, perceived stress, ongoing life events, and optimism)
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and social network. To be eligible, participants had to be aged 45 – 74 years, have a life
expectancy >5 years and be available for baseline or annual follow-up visits. Pregnancy or HIV
status was not an exclusion criteria.

Study population and Eligibility Criteria
To answer the research questions associated with this study, individuals from the Heart
SCORE study cohort with a prior history of coronary heart disease such as myocardial infarction
(MI), percutaneous coronary intervention (PCI), cardiac catheterization or coronary artery bypass
graft (CABG) (n=88). Also, individuals who did not report on race or identified with a race other
than Black or White were excluded (n=51). Thus, the final sample size comprised of 1,861
individuals.

Study Outcomes
The primary study outcome was a composite outcome of incident major adverse cardiac
events (MACE) defined as the first occurrence of myocardial infarction, cardiac death or any
revascularization such as percutaneous coronary intervention (PCI) or coronary artery bypass
graft (CABG). The timing and occurrence of the events were confirmed through medical records
and adjudicated by medical experts.
To assess the impact on chronic stress on other cardiovascular diseases, an additional
sensitivity analysis was performed by creating a composite CVD outcome that includes CHD
(MI, revascularization or cardiac death) and ischemic stroke.
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Study Variables
To examine the incremental benefit of including chronic stress in cardiovascular risk
equations, three measures of chronic stress were created as follows:
Cumulative Reported Chronic Stressors (CRCS)
Six stressors frequently measured in the stress and cardiovascular literature were
identified and used to calculative a cumulative stress score based of the presence or absence of
each stressor. These stressors represent six domains such as financial stress 116,117, perceived
discrimination 118, social isolation 119, neighborhood stress 112,113, caregiving stress 120, and jobrelated stress 99. Social isolation was eliminated from the final derivation of the cumulative stress
score due to poor correlation with other stressors and its removal improved the Cronbach alpha
(0.49 to 0.55). Thus, the range of the cumulative chronic stress score was 0 – 5. Participants were
subsequently classified into three (3) groups namely: None (0), moderate (1), and high exposure
to CRCS (≥2) based on tertiles. Pearson correlations between each stressor was also measured.
See table A4 for the definition, classification of each stressor, and correlation with each other.
Measures of Stress Response
The global perception of stress (“feeling of being stressed”) in response to life stressors
was measured using the 4-item Cohen’s perceived stress scale 121 while the biological response
was measured using allostatic load (AL). Perceived stress was measured using the 4-item
Cohen’s perceived stress scale (PSS-4; range: 0 – 16), a shorter version of the PSS-10. The PSS4 is frequently used in epidemiological studies due to its brevity and has previously been
validated in other studies 122. Although concerns have been raised about the low reliability of the
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PSS-4 instrument 123, the PSS-4 had acceptable reliability in our study population (α=0.79).
Participants were subsequently divided into terciles according to the distribution of the PSS-4
score: Low (0-3), moderate (4-5), and high (≥6) perceived stress.
The second derived measure of the stress response was allostatic load (AL). The allostatic
load was measured using 10 biomarkers across three domains: Inflammatory (hs-CRP and IL-6),
metabolic (fasting blood glucose, waist-hip ratio, serum creatinine, and urine albumin) and
cardiovascular (systolic blood pressure, diastolic blood pressure, triglycerides, and very low
density lipoprotein). Individuals were classified as high or low risk for each biomarker if it fell
outside or within the normal clinical range, respectively. Sex-specific clinical cutoffs were used
for waist-hip ratio and serum creatinine. Individuals on anti-hypertensive and lipidemic agents
with values within normal range were considered to be low risk. Each individual was
subsequently assigned a score of 1 or 0 if they were classified as high or low risk, respectively.
These scores were summed to get the allostatic load with a possible range of 0 – 10. This
approach of deriving the allostatic load using clinical rather than empirical cutoffs is frequently
used in the AL literature 124. See table A3 for the clinical cutoffs of biomarkers used in
computing the AL. The calculated Cronbach alpha for all biomarkers used in calculating the AL
score was 0.6. For the purpose of assessing agreement between measures of chronic stress,
participants were divided into three groups based on terciles of AL score: low (0 – 1), moderate
(2 – 3), and high (≥4).
Cardiovascular Risk Scores
The 10-year Framingham risk score (FRS) or expected risk of CVD was calculated using
the approach described by D’Agostino et al 125. Similarly, the 10-year Pooled Cohort Equation
(PCE) risk scores were computed using the equation described by Mutner et al 126.
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Cardiovascular Health
An ideal cardiovascular health score was calculated for each individual as recommended
by the American Heart Association (AHA) 127. Participants were assigned a value of 0, 1, or 2 if
the values of each component of the life simple 7 (LS7) was poor, intermediate or ideal. Finally,
a total score was calculated by summing all values and categorizing individuals into poor,
intermediate or ideal according to empirical cutoffs. See Table A13 for the operationalization of
the ICH score.
Other Covariates
Information on other study variables were collected to compare the characteristics of
individuals in each stress group. These included sociodemographic factors such as age, sex, race,
income, insurance status, employment and educational attainment. Clinical factors such as
systolic blood pressure (SBP; mm/hg), diastolic blood pressure, high density lipoprotein (HDL;
mg/dl), history of hypertension, and history of diabetes were also included. Finally,
anthropometric (waist circumference, waist-hip ratio, BMI), behavioral (current smoking status,
self-reported quality of life), and psychosocial factors (ongoing life events (OLE), depressive
symptoms measured using Center for Epidemiological Studies Depression Scale (CES-D), and
optimism measured using Life Orientation Test (LOT), were included. OLE, depressive
symptoms and optimism were included to assess concurrent and discriminant validity of the
derived measures of chronic stress.

31

Statistical Analyses
The reliability of all instruments and derived scores (CRCS and AL) was calculated using
Cronbach Alpha while the agreement between each measure of chronic stress was assessed using
weighted Kappa statistics. Once constructed, the distribution of study covariates was examined
by each measure of chronic stress and differences between groups within each measure of stress
were assessed using Chi-square test of independence for categorical variables and ANOVA for
continuous variables. Pearson and Spearman rank correlation tests were used to assess the
correlations between each measure of stress and related constructs such as depressive symptoms
and optimism.
Before conducting the regression analyses using Cox models, the proportional hazard
assumption was tested using time dependent covariates by creating an interaction term of each
measure of chronic stress and log of time. The resulting non-significant p-values confirmed the
assumption was met. To determine if chronic stress added predictive information to
cardiovascular risk equations, Cox proportional hazard regression models with calculated FRS
scores were compared with models with FRS score and a measure of chronic stress using the test
of negative two log likelihood ratio tests of nested models (-2LLR) 128. A small p-value (<0.05)
was indicative that the measure of chronic stress provided additional information to the model.
Models were also compared using the Akaike information criterion (AIC) where smaller values
were indicative of a better fit. Subsequently, Harrell concordance index (c-statistic) was
calculated and compared with each model. In instances where the c-statistic appeared to improve
with the addition of a measure of stress, the c-statistic was internally validated using 100
bootstraps to mitigate the effect of optimism arising from comparing predictive performance of
two models with the same data 129,130. Bootstrapping was conducted for the model with FRS or
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PCE alone and the appropriate measure of chronic stress using logistic regression models. To
quantify the incremental clinical benefit of the predictive measure of stress, the event and nonevent Net Reclassification Index (NRI) were calculated 131. To calculate the NRI, the 10-year
predicted probabilities of having the event were calculated for individuals using the coefficients
from a Cox model. These probabilities were subsequently categorized into four clinically
significant groups: 0-<5%, 5-<10%, 10-<20%, and ≥20%. Subsequently, the NRI among those
with the event was calculated as the difference between the probability of an upward
reclassification and the probability of downward reclassification. Similarly, the NRI among
subjects without the event was calculated by taking the difference of the probability of a
downward reclassification and the probability of an upward reclassification. The NRI was only
calculated in instances where the LR test was significant.
Sub-group analyses by age (45 – 55; 56 – 65; 66 – 75 years), sex (males and females),
race (Blacks and Whites), income (<$20,000 vs ≥$20,000) were conducted. Further stratified
analyses among mutually exclusive income and racial groups were also conducted. The cutoff of
income was chosen because the average poverty level for a family of four between the years of
recruitment (2003 – 2006) was $19,150 (aspe.hhs.gov). Furthermore, because the primary
objective was assessing predictive performance, only complete data were used in all analyses.

RESULTS
The study population consisted of 67% females, had an average age of 58.8 (7.5), a high
percentage of self-reported Blacks (43.5%), approximately 82% had an annual income ≥$20,000,
were highly educated (81% had at least some college degree), 60% were employed, 76.3% had
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private insurance while 6.4% had no insurance. Although 88.3% rated their quality of life was
good or excellent, the prevalence of cardiovascular risk factors was particularly high. These
include a history of hypertension (41%), history of smoking (52%), high cholesterol (24%), and
physical inactivity (40.5%). Using the LS7 score, only 14% had ideal cardiovascular health. See
table A1.
Using the three measures of chronic stress, 17.3%, 20.1%, 31.4% of the population were
classified as having high chronic stress according to CRCS, allostatic load and perceived stress,
respectively. There was congruence across all measures of stress when comparing people
classified in high stress groups to moderate and low stress groups. Individuals in the high stress
groups were generally younger, Black, female, less educated, lower income, depressed, and had
poorer cardiovascular health compared to individuals in the moderate to low stress groups. These
differences were statistically significant.
The validated instruments showed good reliability in the sample. The Cronbach alphas
ranged from 0.67 for the OLE to 0.92 for the CES-D (see Table A2). Furthermore, the Cronbach
alpha of variables used in creating the cumulative chronic stress score and allostatic load showed
modest reliability (0.55 and 0.6, respectively). See Tables 3 and 4. Allostatic load had the
weakest agreement with other three-level chronic stress measures (AL vs PSS, κ =0.02; AL vs
CRCS, κ =0.11) while CRCS had a stronger agreement with PSS (κ=0.20). Last, all three
measures of chronic stress were positively correlated with measures of depressive symptoms and
negatively correlated with optimism, however, the association was stronger for CRCS and PSS.
See tables 5a and 5b.
There were 93 events of CHD over a median follow-up time of 12.1 years. This equates
to a cumulative incidence of approximately 5% or an incidence rate of 49 new cases of CHD per
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10,000 individuals per year. A higher percentage of individuals with incident CHD were
classified as being stressed compared to individuals without CHD (53.8% vs 51.7% for CRCS
and 63.1% vs 55.9% for PSS). However, these differences did not reach statistical significance.
Conversely, 70.8% of individuals with CHD were classified as having moderate to high allostatic
load compared to 60.5% without CHD (p=0.04).
Cox proportional hazards regression models evaluating the incremental value of
including measures of chronic stress resulted in null findings when using the total study
population. This persisted for models stratified by sex, race, and income. When the population
was stratified by race and income, CRCS provided incremental benefit to CVD prediction among
low income Blacks. The c-statistic increased from 0.635 (FRS only) to 0.718 with a difference in
Likelihood ratios of 4.9 approaching statistical significance, despite the small sample size
(p=0.08). See Table A6. These results were confirmed using PCE for low income Blacks where
the AUC increased from 0.625 to 0.703 after including CRCS (difference between LR=5.3,
p=0.07). Internal validation of model performance using bootstrapping resulted in a c-statistic of
0.62 and 0.636 for model with FRS only and FRS plus CRCS, respectively. Among high income
Whites, the inclusion of CRCS and FRS worsened the prediction of CVD. AUC decreased from
0.8 to 0.79 and paradoxically, the LR test was marginally statistically significant (LR=6.2,
p=0.05). Among low income Whites, the inclusion of the PSS-4 improved the c-statistic from
0.8775 to 0.9249. However, internal validation using bootstrapping revealed these estimates
were highly optimistic. After bootstrapping, the inclusion of PSS-4 reduced the c-statistic from
0.8789 to 0.8445.
The NRIevent for the model among low income blacks was 0.455 or 45.5% while the
NRInon-event was -0.237 or -23.7%. These results were replicated using the PCE. Furthermore, the
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NRIevent and NRInon-event among high income Whites was 0 and -2.9%, respectively. See tables 6
and 7.

DISCUSSION
The correlation and agreement between three derived measures of chronic stress was
examined. These measures were created based on their role as stressors (cumulative chronic
stressors) and response to stressors (perceived stress and allostatic load). All three measures had
weak agreements and poor correlations with each other. However, perceived stress measured
with the Cohen’s perceived stress scale and the cumulative chronic stress score showed fair
criterion validity with depressive symptoms and optimism. Allostatic load, a physiological
measure of cumulative stress, had the weakest agreement with other measures of chronic stress,
optimism and depressive symptoms.
Three measures of chronic stress were created to determine whether they provided
additional predictive benefit in identifying people at risk of CHD. Although all three measures of
chronic stress were positively associated with risk factors of cardiovascular health, only
cumulative chronic stress provided incremental benefit to risk prediction with traditional risk
factors among low income Blacks. The results showed a 45.5% and -23.7% (worse) net
improvement in the reclassification of cardiovascular risk with the inclusion of CRCS in the
model among those with and without the event, respectively. To the best of our knowledge, this
contributes to the current knowledge base by examining the impact of chronic stress on
cardiovascular risk prediction.
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The income dependent effect of stress was previously reported in the literature. A
prospective cohort study conducted by Redmond et al showed perceived stress measured using
the PSS-4 was associated with increased risk of incident coronary heart disease among low
income Blacks 35. Another study showed that pooled cohort equations (PCE) performed better
among individuals with social deprivation but overestimated individuals with less social
deprivation 132.
Results also show that univariate associations between measures of chronic stress and
CHD were statistically non-significant. This result was unexpected but isn’t entirely surprising
given that people in high stress groups were relatively younger than those in the lower stress
groups. Age is the most important risk factor in CHD and analyses that fail to control for age will
have similar findings. Upon stratification, the results are in the expected direction (result not
shown). However, only PSS-4 reached statistical significance.
The weak agreement between measures of chronic stress was unexpected. While the
results need to be replicated in a larger, representative cohort, the poor agreement is unlikely due
to the chosen cutoffs in this study. If it were the case, we would expect stronger correlations
between the raw, uncategorized measures, however, in congruence with the agreement scores,
this was not the case. One explanation could be related to the difference in perception of stress
and the presence of resilience factors among those exposed to multiple stressors. It is plausible
that the detrimental effect of stress on health would only matter if people exposed to multiple
stressors perceive their situation as stressful. In reality, this may not be the case due to resilience
and personality traits. Thus, an individual exposed to multiple stressors may not perceive their
situation as stressful while someone exposed to few stressors might and could explain the weak
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linear correlation. Therefore, future research could consider defining chronic stress at the
intersection of these two measures.
The agreement was weakest with allostatic load compared to other measures of stress.
This is surprising because allostatic load represents the physiological response to stressors like
neighborhood deprivation 133. The lag between exposure to chronic stress and development of
AL might explain this association and is recommended for future research.
Despite higher prevalence of perceived stress among Blacks and its known association
with CHD, the inclusion of PSS-4 did not improve the performance of FRS among low income
Blacks. This further underscores the need to validate the psychometric properties of the PSS-4 in
minority populations, specifically in relation to CHD.
The implications of this finding has public health and clinical relevance. Given the
susceptibility of exposure to multiple stressors, low income Blacks may benefit from enhanced
screening for stressors during physician visits and promotion of interventions to offset the effect
of stress such as provision of food markets in the community, access to food pantries, referrals to
community organizations to address unmet social needs and increased health education materials
to reduce cardiovascular risks. This messaging maybe timely with the clamor for surveilling
social health and addressing unmet social needs 134. Ensuring individuals with unmet social
needs such as financial assistance, access to food, and medication assistance receive the
necessary assistance may alleviate the stress experienced by these individuals 135,136.
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This study was conducted using extant data and is limited by potential measurement error
in the original dataset. Furthermore, the results of these analyses are generalizable to the source
of the study population, Pittsburgh Pennsylvania.
There was limited sample size among low income Blacks. While results were further
confirmed with bootstrapping analysis, the results need to be validated in a larger cohort of low
income Blacks. In addition, the event rate in the study was low (5%) and may negatively impact
statistical power. However, several studies examining risk factors in incident CHD have reported
similar event rates .
Neighborhood deprivation was calculated by linking available addresses of study
participants at enrollment to publicly available 2013 ADI. There are two noteworthy limitations.
First, linkage was not feasible for approximately 12% of participants due to incomplete address.
Second, it is likely an individual residing in a highly deprived neighborhood in 2003 might be
misclassified as living in an affluent neighborhood in this analysis if the neighborhood
underwent substantial gentrification. It is difficult to estimate this percentage. Last, it is also
likely a participant might have changed residence over the course of the study, however, only
7.7% of the original population changed residence. Recent evidence suggests individuals
classified as living in a highly deprived neighborhood are likely to move to a neighborhood of
similar depravity 137. Other research show that neighborhood deprivation measured at one time
point is as predictive multiple measurements 138
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CONCLUSION
Three measures of chronic stress were weakly correlated with each other but were
associated with poor ideal cardiovascular health and disproportionately affected Blacks
compared to Whites. However, only cumulative measure of chronic stressors provided
incremental predictive benefit to predicting CHD among low income Blacks. Further research is
required to delineate the mechanisms driving this association in this subgroup.
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CHAPTER 4
SPECIFIC AIM 2

INTRODUCTION
Despite declining mortality and morbidity rates in cardiovascular diseases (CVD), racial
disparities persist. Non-Hispanic Blacks (NHB) experience higher incidence rates of coronary
heart disease (CHD) (6.6 vs 3.8/1000), worse CVD-related mortality rates (150.6 vs
137.5/100,000) 2, experience stroke at a younger age (4:1 among 45 – 55 years old) and
experience higher mortality from stroke (66.8 vs 47.2/1000,000) than Non-Hispanic Whites
(NHW) 139. These disparities in cardiovascular outcomes are associated with the disproportionate
exposure to traditional risk factors. Numerous studies report higher prevalence of traditional or
proximate risk factors including high blood pressure 51, diabetes 52, cigarette smoking among
adult males 57, and adiposity 53 among African Americans relative to other racial groups in the
US. Differences in socioeconomic status 140,141, medication adherence 142, and genetics 143 are
postulated to be contribute to these disparities, however, they do not fully account for the excess
cardiovascular mortality among NHB and other racial groups including NHW.
Stress is an independent risk factor of coronary heart disease 13. Evidence from the
literature suggests that the risk of incident CHD increases by 47% with work-related stress 90,
82% in women who look after a spouse for ≥ 9 hours per week 97, a 2.4 fold increase among
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people with moderate or high financial stress 105, and 14% among men who experience
discrimination 108. However, the conclusion is not unequivocal. Some studies reported nonstatistically significant associations of some measures of stress and incident CHD such as
perceived stress 111,144, perceived racism 110, and job strain 92,145. Nonetheless, results from a large
body of research suggest chronic stress is associated with CVD 13,16,33,146. Chronic stress is
purported to influence the development of CVD risk factors such as hypertension, and promotes
the indulgence in behaviors such as smoking and physical activity that subsequently lead to
cardiovascular disease24. It could also accelerate the progress of age-related diseases such as
CHD through alternative pathways by maintaining a chronic state of inflammation and
shortening of telomeres 62.
In the United States, most studies assessing the association between stress and CVD
typically involve stressors such as perceived discrimination 104,108,111 and neighborhood
deprivation112,113,147. This approach is driven by a long standing hypothesis suggesting that NHB
suffer worse health due to socioeconomic inequalities 141, plausibly leading to greater exposure
to multiple stressors across multiple domains compared to other ethnic groups. Therefore,
quantifying the role of chronic stress – measured by exposure to stressors across multiple
domains- could potentially delineate the CVD disparities between African Americans and other
ethnic groups.
Mediation allows the estimation of effects that explain the pathway through which an
exposure affects an outcome. These effects are typically decomposed into total effects, direct
effects (natural and controlled), and indirect effects (natural). Below are definitions of these
effects.
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Definition of effects 148–151
1) Total Effects (TE): This represents the total effect of the exposure on the outcome,
accounting for confounders between exposure and outcome and mediator and outcome. It
can be decomposed further into natural direct and indirect effects.
2) Natural direct effect (NDE) represents the effect of the exposure on the outcome when
the mediator is set to its natural value under the referent exposure value or in the absence
of the exposure. The counterfactual notation for NDE is Y1M0-Y0M0 where M0 is the
value the mediator would assume in the absence of the exposure.
3) Natural indirect effect (NIE) represents the effect of the exposure on the outcome when
the mediator is set to its natural value in the presence and absence of the exposure. Using
the equation Y1M1-Y1M0 where X=1, we see to have a non-zero value, the exposure
would have to change the mediator which then impacts the outcome. Thus, the NIE can
simply be described as the effect of the exposure on the outcome due to the mediator. The
relationship between the TE, NDE and NIE can be expressed by the equation:
TE=NDE+NIE on the additive scale or TE=NDE*NIE on the multiplicative scale.
4) Controlled direct effect (CDE) represents the effect of the exposure on the outcome at a
fixed level of the mediator, assuming exposure-outcome and mediator-outcome
confounding. Counterfactual notations of CDE are Y1xm-Y1x*m where M=m represents a
fixed level of M, x=exposed and x*=unexposed.
5) The proportion mediated quantifies the magnitude of total effects attributable to the
indirect effect of the exposure. It is derived using natural direct and indirect effect.
Proportion mediated is believed to be more suitable to answer etiological questions or
describing the mechanisms an exposure affects an outcome.
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6) The proportion eliminated quantifies the effect that will be eliminated if an intervention
intervenes on the mediator. It is derived using controlled effects and total effects. This
has more policy implications.
The estimation of these effects require the fulfilment of strong causal inference assumptions.
These assumptions include
1) No confounding between exposure and outcome
2) No confounding between exposure and mediator
3) No confounding between mediator and outcome
4) Confounders of mediator and outcome should not be affected by the exposure
These assumptions cannot be tested using data, rather they rely on existing knowledge between
the exposure and the outcome.
To estimate total effects, the first and second assumptions must be met. Assumptions 1 –
4 are required for estimating natural direct and indirect effects. Given race as the exposure in this
study, assumption 4 will be difficult to meet because it’s highly conceivable that most variables
associated with stress are associated with race. However, this fourth assumption is not required
to estimate controlled direct effects of race on CHD.
Other studies have examined the mediating effect of chronic stress in cardiovascular
disease. However, these studies were cross-sectional and conducted in women only 107,152,153 or
assessed the association treating stress using the difference method 154 with limited control of
confounding.
Thus, the objective of this chapter is threefold: (1) to calculate the relative risk of CHD
between non-Hispanic Blacks to non-Hispanic Whites, (2) the racial disparity that would remain
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and (3) proportion eliminated after setting cumulative chronic stress to its baseline referent
values will be calculated using data from an ongoing, biracial prospective cohort study of men
and women.

METHODS
Recruitment and Data source
This project will utilize extant data from the Heart Strategies Concentrating on Risk
Evaluation (Heart SCORE) study. Heart SCORE is an ongoing prospective cohort and
community-based study of 2,000 community dwelling individuals aged 45-75 years in
Pittsburgh, Pennsylvania. The primary goal of the Heart SCORE study is to identify mechanisms
that explain population differences in cardiovascular disease outcomes for the purposes of
eliminating racial disparities in CVD 115.
Recruitment of study participants began in 2003 and involved direct mailing of
questionnaires, community and physician referrals, print and electronic media, and public service
announcements. Data were collected at baseline and during annual follow-up visits on
characteristics such as sociodemographic, clinical markers, medical history, psychosocial risk
factors (depression, hostility, anger, anxiety, perceived stress, ongoing life events, and optimism)
and social network. To be eligible, participants had to be aged 45 – 74 years, have a life
expectancy >5 years and be available for baseline or annual follow-up visits. Pregnancy or HIV
status was not an exclusion criteria.
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Study population and Eligibility Criteria
To answer the research questions associated with this study, individuals from the Heart
SCORE study cohort with a prior history of coronary heart disease such as myocardial infarction
(MI) and coronary revascularization were excluded (n=88). Furthermore, individuals who did not
report on race, identified with a race other than Black or White, or identified as Hispanics were
excluded (n=177). Thus, the final sample size comprised of 1,735 Non-Hispanic Whites and
Blacks.
Study Outcomes
The primary study outcome was a composite outcome of incident major adverse cardiac
events (MACE) defined as the first occurrence of myocardial infarction, cardiac death or any
revascularization such as percutaneous coronary intervention (PCI) or coronary artery bypass
graft (CABG). The timing and occurrence of the events were confirmed through medical records
and adjudicated by medical experts. Participants were censored if they didn’t experience the
study outcome as of April 2019. The time to censoring or experiencing an event was calculated
as the difference between date of enrollment and censoring or event and expressed in days.
Study Variables
To quantify the role of chronic stress in the Black-White disparity in CVD outcomes, the
following variables were utilized:
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Exposure
The main exposure in this study was self-reported race. Participants were asked to select one race
regardless of their ethnicity. Options followed the five categories of race recommended by the
Office of Management and Budget (OMB) including American Indian or Native Alaskan, Asian,
Black or African-American, Native Hawaiian or Pacific Islander, White or Other.
Mediators
Two measures of chronic stress were considered as mediators. The first was the cumulative
chronic stressor and the perceived stress scale score as determined by the Cohen’s PSS-4 due to
their modest agreement witnessed in the previous chapter. These two measures were
dichotomized to classify individuals as either having low or high stress to facilitate meaningful
interpretations with policy implications. Individuals who lacked any chronic stressor as defined
by the chronic stress score were classified as having low stress while those with at least one
stressor were classified as having high stress. The components of these measures are described in
chapters 3 of this dissertation.
Similarly, individuals with a PSS-4 score below 4 were categorized as having low stress
while others with a score of 4 or higher were classified as having high stress. Although the initial
approach was to model the trajectories of chronic stress over time, the post-hoc analysis showed
the group membership at baseline appeared constant over six years of follow-up (figures 2.1 and
2.2). Thus, to obtain a parsimonious model, group classification at baseline was used in the
analyses.
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Covariates
Information on other study variables were collected to compare characteristics of
individuals who self-identify as Black or White. These included sociodemographic factors such
as age, sex, race, income, insurance status, employment and educational attainment. Clinical
factors such as systolic blood pressure (SBP; mmhg), diastolic blood pressure, high density
lipoprotein (HDL; mg/dl), history of stroke, history of hypertension, and history of diabetes were
also included. Finally, anthropometric, behavioral, and psychosocial factors like waist
circumference, BMI, current smoking status, and depressive symptoms measured using Center
for Epidemiological Studies Depression Scale (CES-D).
A depiction of the hypothesized relationship between the exposure and the outcome is shown in
figure 2.3.
Statistical Analyses
Univariate and Bivariate Analyses
The characteristics of the study population was summarized using counts and percentages for
categorical variables and mean and standard deviation for continuous variables. Differences in
the distribution of these characteristics by study groups (NHB and NHW) were tested using
Pearson chi-square test and two independent sample t-test for categorical and continuous
variables, respectively.
The cumulative incidence was calculated by taking the proportion of incident cases of MACE
while the incidence rate was calculated by dividing the incident cases of MACE by the sum of
follow-up time and expressed in person-years. These measures of incidence were calculated
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among NHB and NHW. Furthermore, the cumulative incidence of MACE was examined by
overall CRCS, its individual components, and the dichotomized measure of perceived stress.
Breslow-Day test was conducted to examine heterogeneity of incidence rate between NHB and
NHW by age groups (45 – 55, 56 – 65, 66 – 74), sex (male and female) and income (≤$20,000,
$20,001 to $80,000, > $80,000). Incidence rate ratios and their 95% confidence intervals were
calculated by fitting a model with a Poisson distribution and a log link within each subgroup.
Mediation analyses were not conducted in these subgroups.
A pair of subject-level stabilized IP weights were created by fitting two logistic
regression models. The first regressed the binary stress variable on race, exposure-outcome
confounders, and mediator-outcome confounders. The second, regressed race on exposureoutcome confounders only. These confounders are listed in Figure 2.3. The propensity scores
from both models were used to generate weights as follows (1/Pstressed and 1/1-Pstressed for those
stressed and not stressed respectively) and (1/PBlack and 1/1-PBlack for those self-identified as
Black). To improve precision and mitigate occurrence of extreme weights, stabilized weights
were produced by replacing the numerators with the mean of the proportion (𝑝̂ ) classified as
stressed and Black, respectively (SWstress=𝑝̂ stress/ Pstressed or 𝑝̂ stress/ 1-Pstressed; SWrace=𝑝̂ race/ PBlack
or 𝑝̂ race /1- PBlack ). Thus, the final subject-specific IP weights were calculated as SWstress*SWrace.
Weighted Cox proportional hazard regression models were fit using Proc PHREG with
the SW in the Weight statement. Components of the model include race, stress and the
interaction term of race and stress. Using the CDE, the proportion eliminated will be calculated
using the formula

𝑇𝑜𝑡𝑎𝑙 𝑒𝑓𝑓𝑒𝑐𝑡−𝐶𝐷𝐸
𝑇𝑜𝑡𝑎𝑙 𝑒𝑓𝑓𝑒𝑐𝑡−1

and expressed as percentages. Two total effects were

calculated from models with and without adjustment of CHD risk factors. This approach allows
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for the assessment of a direct and indirect effect of stress on CHD. The model without
adjustment for risk factors of CHD included the following covariates: age, sex, income,
education, insurance status, family history of pre-mature CHD, history of renal disease and
depression. The second total effect will be calculated from a model that includes the
aforementioned covariates and risk factors of CVD such as: smoking status, waist circumference,
physical activity, systolic blood pressure, and total cholesterol.
The total and controlled direct effects were expressed as risk differences (RD) using a
ten-year cutoff. Therefore, all subjects who experienced the event after 10 years were assigned a
value of 0. Among those without the event, 9.7% and 25% were lost to follow-up before the 5th
and 10th year. However, censoring was not accounted for in this analysis. The RD for total effect
was calculated by fitting an unweighted linear model with robust standard errors containing race
and exposure-outcome confounders as covariates and a binary outcome of CHD. Similarly, a
weighted linear model with robust standard errors containing binary indicators for four groups:
NHB + ≥1 stressor, NHB + no stressor, NHW + ≥1 stressor, and NHW + no stressor to calculate
was fitted to determine the controlled direct effect. The coefficient of NHB + ≥1 stressor
indicator represented the controlled direct effect.
A few sensitivity analyses were performed. First, participant’s addresses taken at study
entry were mapped to the 2013 area deprivation index (ADI) file- which is based off the 5-year
summary file between 2009 and 2013-, it was important to assess the potential of
misclassification. Although few participants changed addresses during the course of the study
(7.7%), it’s highly plausible that the neighborhoods would have undergone gentrification. To
examine the robustness of the results, the analyses were repeated using a cumulative chronic
stress score that was calculated without neighborhood deprivation.
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Furthermore, the primary analysis was repeated using imputed data on missing variables.
About 33% of the study population had missing data on at least one covariate and these data
were imputed using multiple imputation with fully conditional specification (FCS). Variables
used in the imputation model are outlined in table A12.2 located in the appendix. Five
imputation datasets were created and were analyzed individually with the appropriate statistical
method. Final results were subsequently pooled using SAS Proc MIANALYZE to get total
effect, controlled direct effect and subsequent percentage eliminated.

RESULTS
A total of 1,735 were included in the final analyses. Of these, 42.7% were non-Hispanic
Blacks, had an average age of 58.9 (7.5) years and a male to female ratio of 1:2. There were
statistically significant differences in the distribution of sociodemographic, psychosocial, and
cardiovascular risk factors between NHB and NHW. Compared to NHW, NHB were more
likely to be younger (~ 43% vs 32% aged 45 – 55; p<.0001), females (70.6% vs 63.6%;
p=0.002), have an annual income of $20,000 or less (28.3% vs 10.1%; p<.0001), receive
Medicaid/other public insurance (5.3% vs 1.2%; p<.0001), and less likely to have a
Bachelor’s/Advanced degree (58.6% vs 35.4%; p<.0001). NHB were more likely to report
fair/poor quality of life (19.9% vs 5.7%; p<.0001), higher perceived stress (4.6 vs 4.1; p<.0001),
two or more chronic stressors (32.4% vs 5.8%; p<.0001) and higher depressive symptoms (7.5 vs
6.4; p<.0001). Similar statistically significant differences were seen across cardiovascular risk
factors including smoking (13.7% vs 8.3%; p<.0001), waist-circumference (99cm vs 93cm; ),
higher BMI (32.1 vs 28.6; p<.0001), systolic blood pressure (141 vs 133; p<.0001) and lower
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total cholesterol (206 vs 210; p=0.04). Only 6.8% of NHB were classified as having ideal
cardiovascular health compare to 19% of NHW (p<.0001). See table A9.
The overall crude cumulative incidence of MACE was 5% (87/1735) and was similar
among Blacks (5.13%) and Whites (4.93%). Among those with the event, revascularization
procedures accounted for most of the cases (52.3%) followed by cardiac related death (27.6%)
and myocardial infarction (19.5%). NHB were more likely to have MI (21 vs 18.4%) and
cardiac-related death (34.2% vs 22.5%) but were less likely to undergo revascularization (44.7%
vs 59.2%); however, these differences were not statistically significant (p=0.37). Parity was
observed in the crude incidence rates. NHB had an incidence rate of 1.39 per 100,000 persons
per day (5.07/1000/year) compared to 1.31 per 100,000 persons per day (4.8/1000/year).
However, 21.1% and 20.4% of cases occurred within the first year of study entry for NHB and
NHW, respectively.
Stratified analyses showed significant heterogeneity between groups by age at enrollment
(p= 0.038). Although the incidence of CHD increased with age for both groups, the incidence
was larger for younger NHB compared to NHW (3.97 vs 0.92 per 1,000 persons per year) aged
45 – 55 years and resulted in an incidence rate ratio (IRR) of 4.29 (95% C.I.=1.22, 15.06). The
incidence rate per 1,000 persons per year was higher for NHW between ages 56 to 65 years (4.26
vs 5.52; IRR=0.77 , 95% C.I=0.38, 1.53) and marginally higher among NHB for people aged 66
to 74 (9.29 vs 8.67; IRR=0.99; 95% C.I.=0.49, 1.99). Although no statistical heterogeneity was
observed by sex and income groups, stratified analyses revealed higher IRR for NHB compared
to NHW in both sexes and lower income groups. See table A10 and A11.
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Distribution of Study Outcome by Measures of Stress
Unexpectedly, the event rate in stress groups were low. No events were reported among
people classified as having caregiving stress. Overall, the event rate of any CHD was lower
among those classified as having job stress (3% vs 5.2%; p=0.65), financial stress (3.5% vs
5.2%; p=0.41), and living in a deprived neighborhood (4.5% vs 5.4%; p=0.69) compared to
people without these stressors. However, the event rate of CHD was higher among those who
perceived discrimination compared to those who did not perceive discrimination in their daily
lives (5.8% vs 4.7%; p=0.012).
Using perceived stress, the event rate of CHD was higher in the group classified as
having high stress (5.7 vs 4.3%). Assessing each CHD component, the event rate of cardiacrelated mortality was highest among those who perceived discrimination (2.8 vs 0.8%) and
perceived stress (1.9 vs 0.8%) compared to participants without these experiences. Similarly, the
rate of myocardial infarction was highest among those with job-related stress (1.5 vs 0.9%) and
perceived stress (1.3 vs 0.5%). See table A11.2.
To observe the racial disparity in CHD, two sets of analyses were conducted according to
the measure of stress by utilizing a cumulative measure of chronic stressors (CRCS) and a
binary indicator of perceived stress as measures of chronic stress, respectively.
Examining the mediating role of chronic stress in the racial disparity of CHD
The first measure of chronic stress considered is the CRCS. The total effect showed NHB
had higher risk of CHD compared to Whites (HR=1.79, 95% C.I=1.05, 3.05) among 1,443
individuals with complete data. After conducting a weighted cox regression model using
stabilized weights, the racial disparity in CHD that remained by setting the population stress-free
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was 1.45 (95% C.I.=0.7, 3.01). This suggests that 43% of the racial disparity will be eliminated if
NHB were not exposed to chronic stressors. To tease out the specific stressors that contributed
the most to this difference, perceived discrimination or unfair treatment, difficulty at place of
work, and taking care of a family member would reduce the racial disparity in CHD by 52.8%,
34.2% and 10.3%, respectively. However, the estimates for job strain and caregiving stress are
unstable due to sparse data or near zero cells. Examination of financial stress and neighborhood
deprivation showed an increase in racial disparity and resulted in negative percentage eliminated
values. See table A12.1.
The total effect was recalculated by controlling for CV risk factors such as smoking,
physical inactivity, systolic BP, total cholesterol, and waist circumference, in the model. Results
showed that the racial disparity in incident CHD attenuated to 1.44 (95% CI=0.83, 2.51) among
1,378 individuals. The racial disparity that remained and not due to interaction nor mediation
after setting the population stress-free was 1.39 (95% CI=0.64, 3.00). This suggests that the
racial disparity between Blacks with similar sociodemographic and clinical characteristics as
Whites would be eliminated by 12.6% if NHB and NHW were not exposed to chronic stressors.
Examining individual stressors, setting the entire population to not experience discrimination or
unfair treatment completely eliminated the disparity. This was closely followed by experiencing
difficulty at work (97.7%) and caregiving stress (76.7%), however, the estimates may be
unstable for reasons noted above. Similar to the model previously described, the racial disparity
increased when examining financial stress and neighborhood deprivation. See table A12.1.
The second set of the analyses were conducted using perceived stress as a measure of
chronic stress, revealed the controlled direct effect of race on incident CHD as 1.94 (95% CI=
0.82, 4.56) adjusting for a similar group of variables that yielded a total effect of 1.79. However,
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when adjusting for the group of variables that yielded a total effect of race on CHD as 1.44, the
controlled direct effect of race on incident CHD increased to 1.75 (0.72, 4.29). This was
suggestive of some interaction between race and perceived stress and four mutually exclusive
groups were created to further examine this effect. These groups included: NHB reporting high
perception of stress, NHB reporting low perception of stress, NHW reporting high perception of
stress, and NHW reporting low perception of stress. Compared to Whites with low perception of
stress, Whites with high perceived stress had a 2.4-fold increase in risk of CHD (95% C.I.= 1.13,
5.22). This result was similar for NHB with high perceived stress (HR=2.5, 95% C.I= 1.12, 5.58)
Assessment using Risk Differences
In a model adjusting for variables other than CV related factors, 18.7 more cases of CHD
occurred among NHB compared to NHW per 1,000 individuals. The disparity that remained if
everyone was not stressed was 12.5 per 1,000 suggesting 6.2/1,000 Black people would be
prevented from having CHD if the population was not stressed. Adjusting for CV related factors,
the racial disparity attenuated to 10.6/1,000 and the CDE was 9.6/1,000. This suggests that
1/1,000 Black people would be prevented from having CHD if the population was not stressed.
As observed with marginal hazard ratios, the CDE for perceived stress increased. See table A13.
Sensitivity Analyses
The analyses were repeated using CRCS without a measure of neighborhood deprivation.
In the model that yielded a total effect of 1.79, the controlled direct effect of race on CHD was
1.59 (95% CI= 0.83, 3.07) resulting in a proportion eliminated of 24.8%. Furthermore, in the
model that yielded a total effect of 1.44, the CDE increased to 1.48 (0.73, 2.98) and disparity was
not attenuated.
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The analyses were repeated using imputed data. The total effect without controlling for
traditional risk factors of CVD using imputed data was a modest 1.25 (95% CI=0.78, 2.02) and
the racial disparity that remained after setting the population to low chronic stress was 1.03 (95%
CI=0.52, 2.01), representing an 88% reduction in the disparity. Similarly, a 36% and 56%
reduction in the racial disparity was observed when perceived discrimination and perceived
stress were set to their referent levels (low level of stress) while the disparity widened when
neighborhood deprivation, financial stress, and caregiving stress were set to their referent levels.
Interestingly, when traditional CVD risk factors were controlled, the total effect was 1.02 (95%
CI=0.62, 1.67); suggestive of no racial disparity between NHB and NHW. Thus, mediation
analyses were not conducted. See table A14.

DISCUSSION
This study examined the role of two measures of chronic stress in the racial disparity of
CHD. Results suggest that a cumulative exposure to multiple stressors may act as a modest
mediator and effect modifier in the racial disparity of CHD outcomes. The proportion of the
racial disparity eliminated when both racial groups are set to low stress ranged from 12.6% in the
presence of existing CVD risk factors to 43% in their absence. In absolute terms, this means that
as many as 1 to 6.2 NHBs per 1,000 adults could be prevented from having CHD in the absence
of chronic exposure to stress. These effects are modest and suggest exposure to multiple chronic
stressors may play a modest role in the persistent disparities between NHB and NHW in CHD
outcomes. Perceived stress, the other measure of chronic stress, did not explain the disparity
between NHBs and NHWs.
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The cumulative reported chronic stressors (CRCS) classified individuals based on
exposure to any one of the following stressors: financial hardship, job difficulties, caregiving
difficulties, living in a deprived neighborhood or perceived discrimination. The racial disparity
between NHB and NHW that would be eliminated in the absence of chronic stressors was
attenuated when considering a total effect of race on CHD from a model with and without
adjustment for cardiovascular risk factors. This provides two pieces of evidence. First, chronic
stress contributes to the racial disparity in CHD outcomes. Second, this contribution is
independent of the indirect effect of stress on CHD that may occur through promoting behaviors
associated with or leading to CHD risk factors like hypertension or adiposity and favors a
plausible, albeit minimal, direct effect of stress on CHD. The second measure of chronic stress
was measured using the Cohen’s perceived stress scale (PSS). When CV risk factors were
controlled in the model, the proportion of racial disparity eliminated resulted in a negative value
because the CDE moved further away from the null. Stratified analyses suggests that individuals
who report being stressed and have these risk factors are at increased risk of incident CHD.
Therefore, these results are indicative of a dual role of stress- both as a mediator and effect
modifier- in the racial disparities of CHD.
The analyses of individual stressors revealed the effect of the CRCS was driven primarily
by perceived discrimination. Perceived discrimination eliminated the racial disparity that
remained after accounting for SES and established risk factors of CVD. This underscores the
importance of perceived discrimination as a potent stressor and a target for intervention. It could
be that people who perceive to be discriminated report their actual experiences. This may prevent
these individuals from accessing healthcare resources and lead to higher mortality. For example,
an analysis conducted on a multiracial sample of women concluded women who report non-
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racial discrimination were less likely to access cancer screening services 155. Therefore it’s
plausible to conclude that people with these experiences may be less likely to interact with the
healthcare system and less likely to benefit from preventive measures. In this study, persons who
perceived to be discriminated were more likely to die of cardiac related mortality than those
without this experience.
Perceived discrimination is also a known stressor associated with the uptake of unhealthy
behaviors and adversely affect mental and physical health. It increases the likelihood of
anxiety/depression 156, elevated cortisol 157, subclinical CVD 153, incident blood pressure 158,
inflammation 159, and heart rate variability 160. However, the association with cardiovascular
endpoints in prospective studies remain equivocal 111. A study conducted in multiracial cohort,
authors reported everyday discrimination increased the risk of CVD among men and the
association did not vary by race. It also did not matter if the discrimination was attributed to race
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. Therefore, future research should examine how perceived discrimination differentially

impacts NHBs in relation to CHD; especially in the uptake of cardioprotective behaviors and
access to preventive healthcare services may provide some insights.
Various findings from this study are consistent with other studies. First, the distribution
of characteristics by race is consistent with the literature that show NHB report higher exposure
to chronic stressors and have worse cardiovascular health. Second, the overall incidence of
coronary heart disease was marginally higher among NHB compared to NHW but significantly
higher among younger NHB compared to NHW and attenuated in older groups 30,139. Last, NHB
experienced higher incidence of MI, were less likely to undergo revascularization procedures and
experience higher cardiac-related mortality.
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Few studies examining the mediating influence of chronic stress in explaining racial
disparities in cardiovascular diseases have focused on cardiovascular health and resulted in
mixed findings. In the cross-sectional study by Burrough et al, the authors concluded
approximately 13% of racial disparities in ideal cardiovascular health were explained by a
cumulative measure of psychosocial stress in an age-adjusted model107. Although the study
population was restricted to older women, the true effect is may likely be larger given the
methodological approach deployed by the authors 151. Also, a 2018 study by Whitaker et al found
that 27% of racial disparities in CV health behaviors were due to psychological risk factors,
however, only 7% and 1% were linked specifically to racial discrimination and the chronic
burden scale according to age- and sex-adjusted models 140. The authors concluded that most of
the racial disparities in CVH were related to differences in socioeconomic status rather than
psychosocial factors. Despite adjusting for measures of SES, the effect size from this study is
similar to the effect size reported by Whitaker et al.
Financial stress has previously been related to CHD risk factors and overall health. More
recently, a study conducted in NHB showed financial stress increased risk of incident CHD
except when depression was included in the model 105. Therefore, it was unexpected to find the
racial disparity widened when financial stress was examined individually especially despite
bivariate analysis showing NHB reported more financial stress compared to NHW. This
paradoxical finding requires more research.
Another unexpected finding was the increase in racial disparity related with
neighborhood deprivation. Despite NHB living in more deprived neighborhoods than NHW,
setting all participants to less deprived neighborhoods did not eliminate the racial disparity in
CHD. Given established associations between neighborhood socioeconomic conditions and
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cardiovascular disease 147, one possible explanation could be misclassification. Participant
addresses collected at baseline between 2003 – 2006 were geocoded and linked to the 2013 Area
Deprivation Index (ADI). Although the 2013 ADI utilizes the 2009-2013 data from the American
Community Survey (ACS), it may not account for gentrification. Thus, a highly deprived
neighborhood in 2005 could be classified as a lowly deprived neighborhood in 2010 with
gentrification. This was further bolstered by an examination of events by deprivation. It showed
participants in highly deprived neighborhoods were less likely to have the event. Sensitivity
analyses which excluded neighborhood deprivation from CRCS showed some mediation by
chronic stress albeit attenuated.
This study extends the literature by quantifying the contribution of chronic stressors that
predispose NHB to worse CVD outcomes by conducting a formal mediation analyses using hard
CVD endpoints rather than intermediate outcomes like cardiovascular health. Furthermore, these
analyses are based off a prospective cohort study with a good ratio of Blacks to Whites and
consists of males and females, although females are overrepresented. Last, CHD was ascertained
using objective measures rather than self-report
The study is not without limitations. First, the cumulative incidence was low (5%) and
may preclude the ability to calculate CDE and observe statistically significant associations with
other effects. This event rate may be due to 68% of participants who were on anti-hypertensive
therapy at some point during the study. However, other studies with similar definition of CHD
reported similar event rates 35,105. Second, the results were sensitive to missing data as the total
effect from the complete case analysis was significantly higher than the estimate gotten from the
imputed analysis. A descriptive analysis on the previously excluded individuals in the complete
case analysis indicated a larger event rate of MACE/CHD among Whites compared to Blacks
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(8.7 vs 2.1%). Thus, the risk of CHD among Whites might have been underestimated in the
complete case analysis.
Although structural equation modelling (SEM) has the capability of determining direct
and indirect effects, it usually requires assumptions of linearity and normality of all variables
involved. Also, it assumes no confounding of all variables involved in the modeling, making
these assumptions extremely susceptible to violations in biomedical research. SEM also lacks the
ability to handle interactions. The difficulty in satisfying these assumptions and inability to
handle interactions make SEM a less appealing alternative 151.

CONCLUSION
In a biracial sample of men and women, measures of chronic stress modestly explained
the racial disparities in CHD outcomes and was largely driven by perceived discrimination.
Future research should examine the mechanisms through which perceived discrimination
negatively impacts NHBs in the context of CHD.
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Figure 2.1: Average perceived stress score over six years of follow-up by baseline
categorization.

Figure 2.2: Spaghetti plots of perceived stress score over six years of follow-up.
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CHAPTER 5
SPECIFIC AIM 3

INTRODUCTION
Psychosocial stress is a risk factor of cardiovascular disease (CVD) 13,25,146,161. Despite
the consistent association of psychological and social stressors with cardiovascular disease
(CVD), the precise mechanism through which chronic stress affects CVD remains elusive. Stress
is purported to contribute to CVD through cortisol- the primary mediator of the hypothalamicpituitary adrenal (HPA) axis

162

. However, the measurement of cortisol as a biomarker of

chronic stress challenging due to its high binding capacity to plasma proteins and diurnal
fluctuations 163,164. Although hair cortisol presents a good alternative for measuring chronic
stress, absence of standardized reporting and susceptibility to damage from chemicals like bleach
impede its utility in epidemiological research 164.
Utilization of metabolomic data might facilitate the identification of biomarkers
associated with the stress response. Metabolomics is a burgeoning field that permits the study of
small molecules involved in biological processes, including chronic diseases such as CVD 165.
Adaptation of an epidemiological-based approach to metabolomic data may uncover metabolites
linking chronic stress with CVD and unearth potential targets for prevention strategies. Previous
application of metabolomic data to identify mediators of psychological conditions such as posttraumatic stress disorder (PTSD) 166, chronic stress in animals 167,168, depression 169 and
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cardiovascular disease 165,170–173 are noted in the literature. However, to the best of my
knowledge, no study has examined metabolomic data in relation to chronic stress in humans.
Ideal cardiovascular health (ICH) is a concept established and propagated by the
American Heart Association (AHA) as a primordial prevention strategy to improve
cardiovascular health at the population level 127. It is defined as the simultaneous presence of
seven health behaviors and factors. These health behaviors include abstinence from smoking
within 12 months, ideal body mass index (BMI) of 18.5 -24.9 kg/m2, physical activity at goal,
and consumption of a cardiovascular health-friendly diet. Similarly, the health factors include
abstinence from smoking within the previous 12 months, untreated total cholesterol <200 mg/dL,
untreated blood pressure <120/<80 mm Hg, and absence of diabetes mellitus127. A cumulative
score based on meeting each criteria can be calculated and is a prognostic factor for
cardiovascular disease 174,175.
Therefore, the objectives of this exploratory analysis are threefold. First, the study will
determine if there are differences in the metabolomic profile between individuals exposed to
chronic stress. Second, the study will determine if these identified metabolites are associated
with ideal cardiovascular health. Last, the identified metabolites will be examined for their
association with the development of cardiovascular disease (CVD).
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METHODS

Study Design and Data Source
This prospective cohort study uses extant data from the Heart Strategies Concentrating on
Risk Evaluation (Heart SCORE) study. Heart SCORE is an ongoing prospective cohort and
longitudinal study of 2,000 community dwelling individuals aged 45-75 years in Pittsburgh,
Pennsylvania. The recruitment and objective of Heart SCORE study is described in previous
chapters.

Study Population
To identify metabolites associated with stress and subsequent CVD, this study included
individuals from the Heart SCORE study cohort without prior history of cardiovascular disease.
Individuals who did not undergo a metabolomic analysis (n=80), had a history of MI or
coronary revascularization (n=88), utilized corticosteroids 48 hours before study entry(n=118),
did not identify as non-Hispanic Black or White (n=177), and had missing data on relevant
variables (n=157) were excluded from the study. This resulted in a final sample size of 1,380
individuals for analysis.

Definition of Study Outcomes
The primary study outcome was ideal cardiovascular health. It was calculated by initially
grouping participants into three groups and assigning a numerical value: ideal (2), intermediate
(1), and poor (0) based on their self-reported values on seven factors and behaviors such as BMI,
blood pressure, blood glucose, physical activity, diet, smoking, and blood glucose at baseline.
Thus, the total ideal cardiovascular health score could range from 0 – 14; with higher scores
denoting ideal cardiovascular health. Individuals were subsequently classified into three groups
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based on this final score: ideal (assigned a value of 2; cutoff: 10-14), intermediate (assigned a
value of 1; cutoff: 5-9) and poor (assigned a value of 0; cutoff: 0-4). The operationalization of
the ICH is described in table A13 of the appendix.

The secondary study outcome was a composite outcome of incident major adverse
cardiac events (MACE) defined as the first occurrence of myocardial infarction, cardiac death or
any revascularization such as percutaneous coronary intervention (PCI) or coronary artery
bypass graft (CABG). The timing and occurrence of the events were confirmed through medical
records and adjudicated by medical experts. Participants were censored if they were lost to
follow-up or didn’t experience the study outcome as at April 2019. Follow-up time -censoring
time or time to experiencing an event- was calculated as the difference in days between date of
enrollment and censoring or event.

Definition of Chronic Stress
The study population was classified into high and low chronic stress as previously
described in the preceding chapter of this dissertation. In brief, the cumulative reported chronic
stress score sums the presence of stressors experienced by each individual. These include
perceived discrimination, residing in a highly deprived neighborhood, experiencing ongoing
financial difficulty, ongoing job difficulties and ongoing caregiving stress. Furthermore, chronic
stress was also measured using the 4-item Cohen perceived stress scale (PSS) and was treated as
a continuous variable.
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Detection and Quantification of Metabolites
Plasma samples of study participants in the Heart SCORE study were collected at
baseline and analyzed using an untargeted ultra-high performance liquid chromatography (UHPLC) with mass spectrometry. This resulted in the identification of 1,228 metabolites consisting
of 893 previously known and 335 unknown metabolites. Metabolites covered a broad array of
biological classes including amino acids, carbohydrates, lipids, and xenobiotics. Extraction,
identification, and quantification of metabolites was conducted by Metabolon®. Metabolon also
assessed platform variability using a set of internal standards in the experimental and process
samples. Results from their analysis showed 7% and 10% relative standard deviation (RSD) for
internal and endogenous metabolites, respectively.
In this study, the metabolite data were cleaned before analysis and are noteworthy. First,
99 technical duplicates used to assess technical variability were excluded. Second, analysis was
restricted to 893 named metabolites. Third, metabolites were excluded from the analysis if they
were medications or metabolites of medications and had missing information on >50% of the
study population 172,176,177. These processes resulted in 718 metabolites available for analyses.
Metabolites with missing data in the population were imputed by using half the minimum value
of the metabolite in the study population 178,179 and all metabolites were subsequently logtransformed to eliminate skewness.
Other study variables
Information on other study variables were collected to account for confounding and
assess relationships with identified metabolites. Variables were included based on their
identification as established risk factors of cardiovascular disease and association with stress.
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These included demographic factors such as age, sex, race, income, and educational attainment.
Traditional risk factors of CVD such as systolic blood pressure, low density lipoprotein (LDL;
mg/dl), current smoking status and history of diabetes were also included. Anthropometric and
behavioral factors like waist circumference and depression were included. Measures of
inflammation such as interleukin-6 (IL-6), highly sensitive C-reactive protein (hs-CRP), and
intercellular adhesion molecules-1 (ICAM-1) were included. Finally, markers of the HPA axis
such as serum cortisol, its metabolite cortisone, and dehydroepiandrosterone sulfate (DHEA-S)
were included for analysis.

Statistical Analyses
The characteristics of the study population were described using mean, median,
frequencies and percentages. Differences between stress groups were tested using Chi-square test
of independence for categorical variables and two independent sample t-test or Wilcoxon rank
test for continuous variables.

To identify metabolites independently associated with high stress, a two-part approach
was taken. First, logistic regression models were created to assess the bivariate association
between individual metabolites and chronic stress. The false discovery rate (FDR) was used to
control the type I error rate and metabolites that met this threshold were deemed to be associated
with stress. For stress measured using the Cohen PSS, simple linear regression was used to
examine the association between metabolites and stress measured using PSS. All metabolites
were checked for multicollinearity using a variance inflation factor (VIF) of 10 and non-collinear
metabolites were included in a logistic regression model that sequentially adjusted for age, sex,
socioeconomic factors (education and income), and race using Backward selection procedure.
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Adjusted odds ratios and their corresponding 95% confidence intervals of metabolites in the final
model were calculated. The metabolites from both models were assessed for their correlations
with inflammatory markers and hormones of the HPA-axis before placed in an ordinal logistic
regression model controlling for age, sex, and race to observe their relationship with ICH. The
proportional odds assumption was assessed to ensure propriety of this modeling approach and
ICH was modeled so that odds were cumulated over poor ICH. The final set of metabolites
associated with ICH were chosen by performing backward selection procedure at an alpha level
of 0.05. This approach was repeated for each component of the ICH. Analyses with total ICH
score was further stratified by Race.

Principal component analysis was used to corroborate the results from the above
analyses. All metabolites were assessed with PCA and components with an eigen value ≥1 were
selected. These components were orthogonally rotated to maximize the variance and ensure zero
correlation between components. Principal components (PC) were assessed with the cumulative
measure of stress controlling for the FDR and were placed in various adjusted models as
described above. To identify the underlying characteristic of each PC, multiple tests of
correlations were conducted between each PC and 718 metabolites. Metabolites with a Pearson
correlation coefficient of ≥0.4 with the PC were identified and collated.

Before conducting a Cox proportional hazards regression to examine the association
between independent metabolites associated with cumulative stress and subsequent MACE, the
proportional hazards assumption was tested using Schoenfeld residual plots and by assessing the
statistical significance of the coefficient of an interaction term between each metabolite and
logarithm of follow-up time. Metabolites that failed to meet this assumption were entered into
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the final model as a time-dependent interaction term. The final Cox proportional regression
model was created by having MACE as the outcome, the metabolites as predictors, and other
study variables: sociodemographic and traditional risk factors of CHD as potential confounders.
Results were further stratified by race. Hazard ratios and their 95% confidence intervals were
calculated and reported. All analyses were conducted in SAS 9.4 and p-values less than 0.05
were considered statistically significant.

RESULTS
The study population consisted of 1,380 individuals with 63 events of MACE over a
median (IQR) follow-up of 12 years (9.1 - 12.3 years), an average age of 58.7 (SD=7.4), 65.4%
female and 56.8% white. About 30% of the study population resided in a deprived neighborhood,
46% earned an annual income $40,000 or less and approximately 18% at least had some college
education. The mean perceived stress and ICH score were 4.3 (SD=3) and 7.1 (SD=2.2),
respectively. See Table A14.
Compared to individuals classified as having low cumulative stress, individuals with high
cumulative stress were younger (57.6 vs. 59.9), female (69% vs. 62%), Black (65% vs. 20%),
income <$40,000 (57.2% vs 34.5%), current smokers (14.7% vs. 6.4%), had a history of diabetes
(12% vs. 6.4%), and less likely to have ideal cardiovascular health (10.4% vs 18.4%).
Individuals classified as having high cumulative stress also had higher waist circumference (97.3
cm vs 94.4 cm), higher depression scores (9.2 vs 4.5), and higher systolic blood pressure (138 vs
135). All differences were statistically significant. There were no statistically significant
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differences between total cholesterol, low-density lipoproteins (LDL), dietary fat, dietary
sodium, serum cortisol, serum cortisone and DHEA-S between the two stress groups.

Metabolic signature of cumulative chronic stressors
Before adjusting for demographic characteristics, 252 metabolites were statistically
associated with high cumulative chronic stress after controlling for multiple testing. After
eliminating highly collinear metabolites and adjusting for sociodemographic variables, 28
metabolites were associated with high cumulative chronic stress. See Table A15. These
metabolites represented amino acids (n=3), lipids (n=13), Cofactors and vitamins (n=4),
xenobiotics (n=7), and a partially characterized molecule. Amino acids were involved in
histidine, leucine, and creatine metabolism. Others were involved in Vit A and nicotinamide
metabolism (cofactors) and xanthine and benzoate metabolism for the xenobiotics. The
association between these metabolites and stress was mixed. The lipid metabolites were involved
in fatty acid metabolism, bile acid metabolism, androgenic steroids, ceramides, diacylglycerol
and phospholipids. androstenediol- a metabolite of DHEA- were less likely to occur in people
with high cumulative stress.
The top five metabolites with the highest odds [OR{95% CI}] of high cumulative stress
include: tetradecanedioate (C14-DC) [2.28 {1.52-3.42}], glycosyl-N-palmitoyl-sphingosine
(d18:1/16:0) [1.93 {1.14-3.28}], retinol (Vitamin A) [1.75 {1.03-2.95}], creatine [1.62 {1.132.31}], and 5-dodecenoylcarnitine (C12:1) [1.5 {1.11-2.03}]. Conversely, the top five
metabolites with the lowest odds of high cumulative stress include: caproate (6:0) [0.53 {0.390.73}], hexadecanedioate (C16-DC), [ 0.55 {0.35-0.85} ], laurate (12:0) [0.56 {0.4-0.78}], 3-
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hydroxy-2-ethylpropionate [0.64 {0.41-0.99}], and androstenediol monosulfate [ 0.68 {0.560.84} ]. See table A15.

Metabolomic signature of perceived stress
Thirty-nine metabolites were associated with chronic stress measured using the Cohen’s
perceived stress scale (PSS) from the univariate analysis. After adjusting for sociodemographic
variables, eight metabolites were associated with perceived stress. These included lipids (n=4)
and one each of amino acids, nucleotide, xenobiotics and metabolite associated with hemoglobin
metabolism. Of these metabolites, only two (sphingomyelin (d18:1/18:1, d18:2/18:0) and 2hydroxybehenate) were positively associated with perceived stress. See table A15.
The metabolites associated with CRCS and PSS are summarized in figure 3.1 at the super
pathway level.

Principal component analysis
Results from the principal component analysis initially identified 128 principal
components from the 718 metabolites in the study. Of these, three were associated with high
cumulative chronic stress. Fourteen metabolites were strongly correlated with these components
and shared a similar pattern with those identified above. They were largely related to lipid
metabolites (n=12) involved in varying pathways, one xenobiotic and one amino acid. The lipid
metabolites were either monohydroxy fatty acids or involved in Phosphatidylethanolamine (PE)
and Phosphatidylcholine (PC) pathways. The amino acid is involved in histidine metabolism
while the xenobiotic is a chemical.
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The analysis was repeated using perceived stress. Four factors were identified and were
strongly correlated with 12 metabolites representing lipids (n=8), amino acids (n=3) and
xenobiotics (n=1). All lipid metabolites were involved in Phosphatidylinositol metabolism or
monohydroxy fatty acids. Like with cumulative chronic stress, the amino acid is involved in
histidine metabolism while the xenobiotic is a chemical. See table A16.

Metabolomic signature of chronic stress and markers of inflammation and the HPA axis
Overall, there were weak positive and negative correlations between markers of
inflammation (Hs-CRP, IL-6, and sICAM) and HPA axis (serum cortisol, cortisone, and DHEAS) with all 36 metabolites. However, 2-hydroxybehenate and glycosyl-N-palmitoyl-sphingosine
(d18:1/16:0) were positively correlated with all markers while docosahexaenoylcholine was
negatively correlated with all markers. See figure 3.2.

Metabolomic signature of stress and ICH
Table A17 summarizes the results of the relationship between metabolites associated with
high cumulative stress and poor ICH. Among the 36 metabolites associated with cumulative
chronic stress and perceived stress, 14 were associated with ICH. Of these, 10 were initially
associated with cumulative chronic stress while four were associated with perceived stress. The
association between the stress-related metabolites and ICH were in opposite directions in 6 of the
14 metabolites, i.e., these metabolites were positively (or negatively) associated with stress but
negatively (or positively) associated with poor ICH. Stress-related metabolites associated with
increased odds of poor ICH [OR (95% C.I.)] include Lipids: sphingomyelin (d18:1/18:1,
d18:2/18:0) [3.34 (1.88-5.96)] , sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)
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[1.84 (1.31-2.58)], 2-hydroxybehenate [1.65 (1.15-2.37)], laurate (12:0) [1.49 (1.10-2.02)],
oleoyl-oleoyl-glycerol (18:1/18:1) [1.24 (1.09-1.41)], and androstenediol (3α, 17α) monosulfate
[1.22 (1.01-1.47)]; Vitamin A metabolites: retinol [2.39 (1.50-3.81)] and a uric acid
metabolite: 3,7-dimethylurate [1.20 (1.05-1.37)]. The stress-related metabolites associated with
reduced odds of poor ICH include a Vitamin A metabolite: beta-cryptoxanthin [0.41 (0.340.48)]; Lipids: tetradecanedioate (C14-DC) [0.70 (0.57-0.87)] and caproate (6:0) [0.67 (0.500.90)]; Nucleotide: 3-aminoisobutyrate (BAIBA) [0.57 (0.44-0.74)]; and Xanthines: methyl-4hydroxybenzoate sulfate [0.88 (0.80-0.96)], and 7-methylxanthine [0.83 (0.73-0.96)]. Stratified
analyses revealed the associations were stronger in Whites than Blacks for sphingomyelin
(d18:1/18:1, d18:2/18:0), BAIBA, laurate, androstenediol, retinol, and beta-cryptoxanthin.
Further examination of the association between the 14 metabolites and each component
of ICH showed beta-cryptoxanthin was associated with a reduced odds of all components except
ideal cholesterol. Similarly, sphingomyelin (d18:1/18:1, d18:2/18:0) and retinol were associated
with five and four components of ICH, respectively. All but two metabolites were associated
with BMI while only three metabolites were associated with blood pressure. See table A18.

Metabolomic signature of stress and Incident MACE
Of the 14 metabolites associated with ICH, only beta-cryptoxanthin was associated with MACE.
Beta-cryptoxanthin, a Vit A metabolite, was associated with a 25% reduction in the risk of
MACE after controlling for sociodemographic factors, systolic blood pressure, total cholesterol,
and current smoking status [HR(95% C.I): 0.75 (0.59 - 0.97)]. There was a significant interaction
effect with race. Upon stratification, the effect was stronger in Whites [0.6 (0.45 – 0.79)] and
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was not associated with a non-statistically significant slight increase in risk of MACE in Blacks
[1.01 (0.63 – 1.62)]. See table A19.

DISCUSSION

This metabolomic study examined the association between metabolites associated with
chronic stress and cardiovascular disease over a median follow-up of 12 years. The results
identified a combined 36 metabolites - involved in lipid, vitamin A, xanthine, amino acid
metabolism-associated with two measures of chronic stress. Of these, 14 metabolites were
associated with ideal cardiovascular health, however, only beta-cryptoxanthin was associated
with a 25% reduction in the risk of incident MACE in the study. This effect was largely driven
by the association in Non-Hispanic Whites.

The results contribute to the literature by identifying a metabolomic signature associated
with cumulative chronic and perceived stress. Although further studies are needed to confirm the
findings, the identification of these metabolites suggest the potential of identifying additional
biomarkers associated with stress beyond cortisol and could delineate the mechanism through
which stress impacts health. Cortisol is rightly heralded as the biomarker of stress in numerous
studies, however difficulties in measurement and diurnal fluctuations have impaired its utility in
assessing health outcomes in epidemiological studies. Given the weak correlation of identified
metabolites with cortisol in these analyses, these metabolites could represent an alternative
pathways of stress response. However, the results need to be validated in a separate cohort.
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Human and animal studies have linked some identified metabolites in this study with
increased morbidity such as stroke 180 [tetradecanedioate], uremic toxin 181 [N1-Methyl-2pyridone-5-carboxamide], prostate cancer 182 [retinol] and depression 169,183 [retinol]. They have
also been identified to be inversely associated with cholesterol 184 [BAIBA] , obesity 185 [betacryptoxanthin], cardiovascular disease 186 [beta-cryptoxanthin], anticancer activity 187
[umbelliferone and beta-cryptoxanthin], and anti-depressant activity 188 [creatine].

Chronic stress has a deleterious effect on numerous health outcomes and if these metabolites are
truly representative of chronic stress, then it might explain the association of these metabolites
with various morbidities. However, because the analyses did not control for these conditions, the
observed association between these stress-related metabolites and ICH may be an artifact. Thus,
these metabolites need to be validated in an independent cohort. Furthermore, an overwhelming
number of metabolites were associated with the lipids biological pathway. This is not
inconceivable given the lipolytic effect associated with the stress response. Stress is also
implicated with unhealthy diet and individuals might indulge in high fat diet. Other biological
pathways implicated include cofactors and vitamins, xenobiotics and require further research.

Of the 36 metabolites associated with measures of chronic stress, 3,7-dimethylurate (a
uric acid metabolite), retinol (vitamin A), 2-hydroxybehenate, and sphingomyelin (d18:1/18:1,
d18:2/18:0) were associated with an increase in stress and odds of poor cardiovascular health.
The consistency in the direction of the associations may suggest these metabolites may be
mediators in the effect of stress on CVD or increase the susceptibility of CHD in individuals with
chronic stress. Although previous studies have not shown increase risk of vit A on the
cardiovascular health, studies have shown an association with 2-hydroxybehenate and
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sphingomyelin. Further analyses suggested this effect was driven by its association with high
BMI. The positive association between Vit A and stress and cardiovascular health is unexpected
given Vit A’s anti-inflammatory effect. Conversely, beta-cryptoxanthin (vit A), 7methylxanthine, 3-aminoisobutyrate, and caproate were negatively associated with stress and
poor cardiovascular health. In this study, beta-cryptoxanthin was consistently associated with
reduced odds of stress, reduced odds of poor ICH health, reduced odds of all components of ICH
except cholesterol and reduced odds of incident MACE. Stratified analyses suggest this
advantage exists only among Whites and not Blacks and might further explain the marginal
favorable outcomes in CVD observed in Whites compared to Blacks.
This is the first study to examine the metabolomic implications associated with chronic
stress in humans. The findings of this work provide preliminary evidence of other biomarkers
associated with the stress response. The study is further strengthened by the large sample size
and diverse demographic profile of the study population, thereby improving the generalizability
of results.

There are few noteworthy limitations. First, the classification of individuals into high and
low stress groups was based on an unvalidated scale with a modest internal consistency (α=0.55).
This could potentially lead to misclassification of individuals in exposure groups. However, the
potential bias was mitigated by classifying people as high stress only if they chose the highest
response on each question. Furthermore, the PSS is a validated scale and a similar pattern of
metabolites were identified. While the overall sample size was sufficient to determine
metabolomic differences in stress 189, there were few events of MACE. The lack of sufficient
events might have limited the statistical power to find additional statistical associations between
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stress-related metabolites and incident CVD. Although this study examined the association of
metabolites measured at a single timepoint with incident MACE, preliminary evidence suggests
levels of metabolites remain stable over two years 190. Last, as with many biomarkers,
metabolites are involved in a myriad of complex biological processes and may lack some
specificity to a particular phenotype or disease. Thus, caution is advised when interpreting these
results.

CONCLUSION
This study examined the metabolomic profile of individuals with chronic stress and its
subsequent association with cardiovascular health and incident cardiovascular disease. Although
one stress-related metabolites was found to be associated with incident cardiovascular disease,
this study contributes to the literature by identifying 36 metabolites associated with stress. Future
studies in a larger, ethnically diverse population are needed to confirm the findings from this
study.
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Figure 3.1: Super Pathway of Metabolites Associated with Chronic Stress

Figure 3.2: Pearson Correlations between Metabolites and Markers of Inflammation and HPA Axis
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS

This dissertation quantified the impact of chronic stress in explaining the racial disparities
observed in cardiovascular diseases (CVD) using data from an ongoing, prospective cohort study
conducted in Pittsburgh, Pennsylvania.
First, chronic stress, defined as a count of exposure to multiple stressors was determined
to provide incremental predictive benefit beyond the Framingham risk score (FRS) and pooled
cohort equation (PCE) among low-income Blacks. In the second manuscript, the racial disparity
that would remain if non-Hispanic Blacks (NHB) had similar exposure to chronic stress as nonHispanic Whites (NHW) was calculated and subsequently used to determine the racial disparity
that would be eliminated. Results showed that the racial disparity would be eliminated by 12.6%
if NHBs had similar to exposure to chronic stress as NHW. However, this result was sensitive to
missing data and both findings would need to be validated in a separate, larger cohort.
Nonetheless, the results underscore the importance of chronic stress in identifying people at risk
of future CVD.
The last manuscript leveraged metabolomic data to identify 36 metabolites associated
with chronic stress. These metabolites were largely lipids and 14 were associated with ideal
cardiovascular health (ICH). Of the 14 metabolites associated with ICH, only one metabolite
(beta-cryptoxanthin) was associated with incident major adverse cardiac event (MACE)- a
measure of CVD, although the association was present exclusively among non-Hispanic Whites.

81

This results suggest other biomarkers could serve as potential markers of chronic stress and
explain the mechanisms stress influences CVD.
A challenge encountered in stress research is the feasibility and effectiveness of
interventions focused on addressing chronic stress due to the pervasiveness of stress 191. It is
conceivable that all humans undergo stress at some point in their lifetime. However, the focus of
this research is chronic stress and the most significant findings in this dissertation were
attributable to exposure to multiple chronic stressors rather than the perception of stress. These
chronic stressors are amenable to intervention. For example, since the 2015 Institute of Medicine
report on the screening, and collection of unmet social needs such as financial assistance 192 was
published, a growing body of literature have assessed the effectiveness of identifying and
addressing patient’s unmet social needs 134,193,194. Furthermore, emerging research suggests
meditation exercises may have a possible benefit on alleviating stress and cardiovascular disease
195,196

while improving resilience might prove to be effective from the deleterious effect of

chronic stress 197. Finally, the results from this dissertation reaffirms the current strategy of early
intervention on traditional risk factors of CVD such as hypertension and diabetes in reducing the
racial disparities in CVD. While numerous research strive to identify other reasons for these
persistent racial disparities in CVD outcomes, it is imperative that ongoing efforts to intervene
on traditional risk factors are equally encouraged.
The findings from the dissertation provided some insights into areas of further research.
For example, when measuring chronic stress, it may be relevant to classify individuals who are
exposed to chronic stressors and perceive their situation as stressful. This approach might
minimize the discordance between exposure to chronic stress and perception of stress from
resilient factors. Another recommendation for further research is the determination of drivers of
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racial disparities of CVD in younger age groups (45 – 55), particularly the interplay of chronic
stress and epigenetic markers. A model that captures early exposure to chronic stress may
uncover the disproportionate high rate of CVD among NHB relative to NHW in this age group.
For example, racial discrimination experienced in multiple settings was associated with
decreased telomere length- an indicator of biological aging- in a small sample of African
Americans with an average age of 39 198. Further application of epigenetics might further explain
the increased racial disparity in this subgroup and provide intervention targets to narrow the
racial gap in CVD outcomes.
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Table A1: Distribution of Characteristics of Study Population by Measures of Chronic Stress
Cumulative Chronic Stress

Perceived
Stress

Allostatic Load

Total

Low

Moderate

High

Low

Moderate

High

Low

Moderate

High

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

(n=1861)

(n=908)

(n=632)

(n=321)

(n=724)

(n=763)

(n=374)

(n=805)

(n=451)

(n=584)

Age (years) , Mean (SD)

58.8 ( 7.5)

60.1 ( 7.4)

58.2 ( 7.4)

56.6 ( 7.2)

57.8 ( 7.3)

59.8 ( 7.7)

58.8 ( 6.9)

60.0 ( 7.3)

59.1 ( 7.6)

57.1 ( 7.1)

Waist-hip ratio , Mean
(SD)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

Waist circumference (cm)
, Mean (SD)

96.0 (15.2)

94.4 (14.3)

96.8 (16.1)

98.9
(15.5)

87.7 (12.0)

98.5 (13.9)

107 (14.7)

96.0
(15.1)

95.6 (15.6)

96.4
(15.1)

Body mass index , Mean
(SD)

30.1 ( 6.4)

29.1 ( 5.9)

30.8 ( 6.6)

31.8 ( 6.6)

26.8 ( 4.2)

31.0 ( 6.3)

34.7 ( 6.7)

30.2 ( 6.4)

29.7 ( 6.1)

30.5 ( 6.6)

Total cholesterol , Mean
(SD)

208 (41.6)

209 (39.3)

207 (42.9)

207 (45.4)

205 (39.7)

208 (42.0)

212 (44.1)

207 (41.5)

208 (42.4)

209 (41.5)

HDL cholesterol , Mean
(SD)

55.7 (16.3)

55.4 (16.2)

56.1 (16.6)

55.6
(16.1)

58.5 (16.3)

55.3 (16.1)

50.9
(15.6)

55.4
(16.9)

56.1 (16.3)

55.9
(15.8)

Systolic BP , Mean (SD)

136 (19.9)

135 (18.4)

137 (21.2)

139 (20.8)

126 (14.1)

139 (18.6)

153 (18.8)

137 (19.4)

136 (19.4)

136 (20.8)

CESD score (>=16 items
completed) , Mean (SD)

6.9 ( 8.0)

4.6 ( 5.3)

7.9 ( 8.3)

11.5
(10.8)

6.4 ( 7.3)

7.0 ( 8.4)

7.7 ( 8.4)

3.1 ( 4.1)

5.6 ( 5.1)

13.1
(10.0)

LOT score (optimism) ,
Mean (SD)

17.2 ( 4.0)

18.0 ( 3.5)

16.8 ( 4.1)

15.6 ( 4.5)

17.3 ( 4.0)

17.1 ( 4.0)

17.1 ( 3.9)

19.0 ( 3.1)

17.3 ( 3.1)

14.5 ( 4.2)

White

1051 (56.5)

727 (80.1)

263 (41.6)

61 (19.0)

488 (67.4)

425 (55.7)

138 (36.9)

474 (58.9)

269 (59.6)

300 (51.4)

Black

810 (43.5)

181 (19.9)

369 (58.4)

260 (81.0)

236 (32.6)

338 (44.3)

236 (63.1)

331 (41.1)

182 (40.4)

284 (48.6)

Subject Characteristics

Race
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Table A1 (Continued)
Gender
Male

615 (33.0)

329 (36.2)

189 (29.9)

97 (30.2)

277 (38.3)

239 (31.3)

99 (26.5)

286 (35.5)

155 (34.4)

169 (28.9)

Female

1246 (67.0)

579 (63.8)

443 (70.1)

224 (69.8)

447 (61.7)

524 (68.7)

275 (73.5)

519 (64.5)

296 (65.6)

415 (71.1)

45 to 55

685 (36.8)

272 (30.0)

250 (39.6)

163 (50.8)

290 (40.1)

255 (33.4)

140 (37.4)

245 (30.4)

160 (35.5)

269 (46.1)

56 to 65

772 (41.5)

401 (44.2)

263 (41.6)

108 (33.6)

309 (42.7)

298 (39.1)

165 (44.1)

349 (43.4)

183 (40.6)

232 (39.7)

66 to 74

404 (21.7)

235 (25.9)

119 (18.8)

50 (15.6)

125 (17.3)

210 (27.5)

69 (18.4)

211 (26.2)

108 (23.9)

83 (14.2)

Less than $10,000

101 (6.0)

22 (2.7)

44 (7.7)

35 (11.7)

34 (5.2)

33 (4.8)

34 (10.0)

28 (3.8)

21 (5.0)

51 (9.8)

$10K to < $20K

205 (12.2)

67 (8.2)

80 (14.1)

58 (19.4)

60 (9.2)

87 (12.5)

58 (17.1)

80 (11.0)

55 (13.1)

69 (13.2)

$20K to < $40K

475 (28.2)

202 (24.7)

165 (29.0)

108 (36.1)

163 (25.0)

212 (30.5)

100 (29.5)

191 (26.2)

113 (26.8)

166 (31.9)

$40K to < $80K

564 (33.5)

276 (33.8)

209 (36.7)

79 (26.4)

226 (34.7)

238 (34.3)

100 (29.5)

248 (34.0)

138 (32.8)

173 (33.2)

$80,000 or more

340 (20.2)

250 (30.6)

71 (12.5)

19 (6.4)

169 (25.9)

124 (17.9)

47 (13.9)

182 (25.0)

94 (22.3)

62 (11.9)

77 (4.2)

0 (0.0)

25 (4.0)

52 (16.3)

25 (3.5)

33 (4.4)

19 (5.1)

17 (2.1)

14 (3.1)

45 (7.8)

Somewhat hard

308 (16.7)

79 (8.8)

137 (22.0)

92 (28.8)

87 (12.1)

127 (16.8)

94 (25.3)

92 (11.5)

75 (16.7)

136 (23.4)

Not very hard at all

1460 (79.1)

823 (91.2)

462 (74.0)

175 (54.9)

605 (84.4)

597 (78.9)

258 (69.5)

688 (86.3)

361 (80.2)

399 (68.8)

266 (14.3)

144 (15.9)

78 (12.4)

44 (13.7)

76 (10.5)

133 (17.5)

57 (15.2)

121 (15.1)

68 (15.1)

74 (12.7)

54 (2.9)

11(1.2)

24 (3.8)

19 (5.9)

17 (2.4)

22 (2.9)

15 (4)

19 (2.4)

14 (3.1)

19 (3.3)

1416 (76.3)

723 (79.9)

477 (75.8)

216 (67.3)

589 (81.7)

558 (73.4)

269 (71.9)

621 (77.4)

341 (75.6)

443 (76.0)

119 (6.4)

27 (3.0)

50 (7.9)

42 (13.1)

39 (5.4)

47 (6.2)

33 (8.8)

41 (5.1)

28 (6.2)

47 (8.1)

Age (years)

Annual income

How hard pay for basics
Very hard

Primary insurance
Medicare
Medicaid/Other Public
Private
None/Self-pay
Education
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Table A1 (Continued)
Less than high school

36 (1.9)

10 (1.1)

24 (3.8)

2 (0.6)

9 (1.3)

17 (2.2)

10 (2.7)

15 (1.9)

6 (1.3)

15 (2.6)

High school diploma

314 (16.9)

140 (15.5)

108 (17.2)

66 (20.6)

100 (13.9)

140 (18.3)

74 (19.8)

121 (15.0)

72 (16.0)

118 (20.3)

Some college

599 (32.3)

227 (25.1)

228 (36.2)

144 (44.9)

207 (28.8)

250 (32.8)

142 (38.1)

241 (30.0)

134 (29.7)

217 (37.3)

Bachelor’s degree

418 (22.5)

221 (24.4)

137 (21.8)

60 (18.7)

176 (24.4)

169 (22.1)

73 (19.6)

178 (22.1)

112 (24.8)

124 (21.3)

Advanced degree

489 (26.3)

308 (34.0)

132 (21.0)

49 (15.3)

228 (31.7)

187 (24.5)

74 (19.8)

249 (31.0)

127 (28.2)

108 (18.6)

Full-time

846 (45.6)

399 (44.1)

290 (46.1)

157 (48.9)

350 (48.5)

329 (43.2)

167 (44.8)

361 (44.9)

210 (46.6)

265 (45.6)

Part-time

274 (14.8)

139 (15.4)

99 (15.7)

36 (11.2)

118 (16.4)

108 (14.2)

48 (12.9)

117 (14.6)

71 (15.7)

83 (14.3)

Retired

497 (26.8)

292 (32.3)

143 (22.7)

62 (19.3)

169 (23.4)

232 (30.5)

96 (25.7)

263 (32.7)

120 (26.6)

112 (19.3)

Other

238 (12.8)

75 (8.3)

97 (15.4)

66 (20.6)

84 (11.7)

92 (12.1)

62 (16.6)

63 (7.8)

50 (11.1)

121 (20.8)

Excellent

303 (16.4)

208 (23.0)

74 (11.9)

21 (6.5)

168 (23.4)

107 (14.1)

28 (7.5)

190 (23.8)

62 (13.7)

50 (8.6)

Very good

673 (36.4)

388 (42.9)

204 (32.7)

81 (25.2)

296 (41.2)

278 (36.7)

99 (26.5)

319 (40.0)

182 (40.4)

162 (27.8)

Good

657 (35.5)

262 (29.0)

258 (41.3)

137 (42.7)

210 (29.2)

281 (37.1)

166 (44.5)

245 (30.7)

158 (35.0)

250 (43.0)

Fair

195 (10.5)

43 (4.8)

80 (12.8)

72 (22.4)

44 (6.1)

84 (11.1)

67 (18.0)

39 (4.9)

45 (10.0)

108 (18.6)

Poor

21 (1.1)

3 (0.3)

8 (1.3)

10 (3.1)

1 (0.1)

7 (0.9)

13 (3.5)

5 (0.6)

4 (0.9)

12 (2.1)

No

1656 (89.2)

845 (93.3)

546 (86.8)

265 (82.6)

645 (89.3)

677 (89.0)

334 (89.5)

737 (91.7)

399 (88.7)

502 (86.3)

Yes

200 (10.8)

61 (6.7)

83 (13.2)

56 (17.4)

77 (10.7)

84 (11.0)

39 (10.5)

67 (8.3)

51 (11.3)

80 (13.7)

Low risk

1048 (57.2)

534 (59.6)

344 (55.5)

170 (53.8)

523 (73.0)

408 (54.4)

117 (32.0)

427 (54.1)

266 (59.5)

340 (59.1)

Intermediate risk

442 (24.1)

230 (25.7)

144 (23.2)

68 (21.5)

129 (18.0)

205 (27.3)

108 (29.5)

207 (26.2)

100 (22.4)

130 (22.6)

High risk

342 (18.7)

132 (14.7)

132 (21.3)

78 (24.7)

64 (8.9)

137 (18.3)

141 (38.5)

155 (19.6)

81 (18.1)

105 (18.3)

Work status past 3 mo.

QOL: Health

Current smoker

Framingham risk strata

102

Table A1 (Continued)
Hx hypertension
No

1097 (59.0)

591 (65.2)

346 (54.8)

160 (50.0)

564 (78.0)

412 (54.1)

121 (32.4)

465 (57.9)

279 (61.9)

340 (58.2)

Yes

761 (41.0)

316 (34.8)

285 (45.2)

160 (50.0)

159 (22.0)

350 (45.9)

252 (67.6)

338 (42.1)

172 (38.1)

244 (41.8)

Poor

785 (42.6)

307 (34.1)

308 (49.4)

170 (53.1)

133 (18.5)

370 (48.9)

282 (76.4)

347 (43.6)

164 (36.7)

269 (46.5)

Intermediate

699 (37.9)

380 (42.3)

204 (32.7)

115 (35.9)

330 (46.0)

299 (39.6)

70 (19.0)

288 (36.2)

199 (44.5)

202 (34.9)

Ideal

358 (19.4)

212 (23.6)

111 (17.8)

35 (10.9)

254 (35.4)

87 (11.5)

17 (4.6)

161 (20.2)

84 (18.8)

108 (18.7)

Poor

188 (10.2)

48 (5.3)

80 (12.8)

60 (18.8)

73 (10.2)

77 (10.2)

38 (10.3)

60 (7.5)

49 (10.9)

76 (13.1)

Intermediate

772 (41.8)

361 (40.1)

267 (42.7)

144 (45.0)

273 (38.0)

345 (45.6)

154 (41.6)

348 (43.4)

188 (41.8)

232 (39.9)

Ideal

886 (48.0)

491 (54.6)

279 (44.6)

116 (36.3)

373 (51.9)

335 (44.3)

178 (48.1)

393 (49.1)

213 (47.3)

274 (47.1)

Poor

746 (40.5)

312 (34.7)

270 (43.3)

164 (51.4)

218 (30.5)

327 (43.3)

201 (54.2)

277 (34.6)

178 (39.8)

290 (50.0)

Intermediate

979 (53.2)

528 (58.8)

323 (51.8)

128 (40.1)

441 (61.8)

389 (51.5)

149 (40.2)

460 (57.4)

245 (54.8)

265 (45.7)

Ideal

115 (6.3)

58 (6.5)

30 (4.8)

27 (8.5)

55 (7.7)

39 (5.2)

21 (5.7)

64 (8.0)

24 (5.4)

25 (4.3)

Poor

546 (29.8)

201 (22.3)

212 (34.5)

133 (41.8)

178 (25.0)

239 (31.9)

129 (34.8)

204 (25.7)

120 (26.6)

220 (38.0)

Intermediate

767 (41.8)

403 (44.8)

252 (41.0)

112 (35.2)

317 (44.5)

298 (39.8)

152 (41.0)

335 (42.1)

206 (45.7)

223 (38.5)

Ideal

520 (28.4)

296 (32.9)

151 (24.6)

73 (23.0)

218 (30.6)

212 (28.3)

90 (24.3)

256 (32.2)

125 (27.7)

136 (23.5)

Poor

451 (24.3)

223 (24.6)

157 (25.0)

71 (22.1)

169 (23.4)

193 (25.4)

89 (23.8)

193 (24.1)

120 (26.6)

134 (22.9)

Intermediate

946 (50.9)

498 (54.9)

289 (45.9)

159 (49.5)

363 (50.3)

396 (52.0)

187 (50.0)

422 (52.6)

219 (48.6)

296 (50.7)

Ideal

460 (24.8)

186 (20.5)

183 (29.1)

91 (28.3)

190 (26.3)

172 (22.6)

98 (26.2)

187 (23.3)

112 (24.8)

154 (26.4)

ICH: BMI

ICH: Smoking

ICH: Physical Activity

ICH: Nutrition

ICH: Cholesterol
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Table A1 (Continued)
ICH: Blood pressure
Poor

842 (45.3)

379 (41.8)

304 (48.1)

159 (49.5)

114 (15.8)

407 (53.3)

321 (85.8)

380 (47.2)

190 (42.1)

270 (46.2)

Intermediate

738 (39.7)

385 (42.4)

235 (37.2)

118 (36.8)

405 (56.0)

286 (37.5)

47 (12.6)

314 (39.0)

199 (44.1)

211 (36.1)

Ideal

280 (15.1)

143 (15.8)

93 (14.7)

44 (13.7)

204 (28.2)

70 (9.2)

6 (1.6)

111 (13.8)

62 (13.7)

103 (17.6)

Poor

136 (7.4)

51 (5.6)

51 (8.2)

34 (10.7)

7 (1.0)

39 (5.2)

90 (24.1)

63 (7.9)

25 (5.6)

46 (7.9)

Intermediate

514 (27.8)

264 (29.2)

155 (24.8)

95 (29.9)

167 (23.3)

236 (31.2)

111 (29.8)

237 (29.7)

113 (25.2)

161 (27.8)

Ideal

1196 (64.8)

589 (65.2)

418 (67.0)

189 (59.4)

543 (75.7)

481 (63.6)

172 (46.1)

497 (62.4)

311 (69.3)

373 (64.3)

Poor

219 (11.8)

71 (7.9)

76 (12.1)

72 (22.4)

16 (2.2)

97 (12.8)

106 (28.4)

86 (10.7)

46 (10.2)

86 (14.7)

Intermediate

1372 (74.1)

672 (74.3)

476 (76.0)

224 (69.8)

501 (69.6)

610 (80.5)

261 (70.0)

597 (74.3)

338 (74.9)

430 (73.6)

Ideal

260 (14.0)

161 (17.8)

74 (11.8)

25 (7.8)

203 (28.2)

51 (6.7)

6 (1.6)

120 (14.9)

67 (14.9)

68 (11.6)

ICH: Blood Glucose

ICH score overall

ICH: Ideal cardiovascular health
Cumulative chronic stress: All p-values were less than 0.05 except for waist-hip ratio, total cholesterol, HDL, and ICH blood pressure
Allostatic load: All p-values were less than 0.05 except for total cholesterol, optimism, smoking, ICH smoking, and ICH cholesterol
Perceived stress score: All p-values were less than 0.05 except for waist-hip ratio, BMI, total cholesterol, HDL cholesterol, systolic blood pressure, Health insurance, Framingham Risk strata, History of
Hypertension, ICH cholesterol, Blood Glucose, and overall ICH.
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Table A2: Internal Reliability of Standardized Instruments in the Study Population

Instrument
Cohen's Perceived Stress Scale (PSS-4)
Everyday Discrimination Scale
Ongoing life events (OLE)
Life Orientation Test (Optimism; LOT)
Center for Epidemiologic StudiesDepression (CES-D)

Alpha
0.786
0.869
0.671
0.787

Sample size
1834
1780
1624
1812

0.92

1784

Number of items
4
10
9
5
20

Table A3: Derivation and Cronbach Alpha of Allostatic Load
Parameters

Domain

Sex-Specific

Highly sensitive C-Reactive Protein
(mg/L)
Interleukin-6 (IL-6) (pg/ml)
Fasting Blood Glucose (mg/dl)
Waist-Hip Ratio (cm)
Serum Creatinine (mg/dl)
Urine Albumin (mg/day)
Systolic Blood Pressure (mmhg)
Diastolic Blood Pressure (mmHg)
Triglycerides (mg/dl)
Very Low Density Lipoprotein (mg/dl)
Cronbach Alpha

Inflammatory
Inflammatory
Metabolic
Metabolic
Metabolic
Metabolic
Cardiovascular
Cardiovascular
Cardiovascular
Cardiovascular

N
N
N
Y
Y
N
N
N
N
N

Clinically
relevant cutoff

Males

Females

3
1.8
126
0.95
1.2

0.8
1.1

30
140
90
200
30
0.6
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Table A4: Correlations of Components of the Cumulative Reported Chronic Stress Measure (CRCS)

Domain
Financial strain 1

Financial strain 2
Perceived
discrimination
Job strain
Caregiving stress

Social Isolation**

Neighborhood
Stress

Measurement
Ongoing financial
difficulty
Difficulty to pay for
basics needs such as
food, housing,
medical needs and
heating?
Perceived
discrimination
score
Ongoing difficulties
at work
Helping at least one
sick, limited or frail
family member or
friend on a regular
basis
Cohen's Social
Network Scale

Area Deprivation
Index

Validated
Instrument
N
N

Y
N
N

Y

Y

Identified as
being stressed
"Yes, very
upsetting"
"Very Hard"

Financial
Strain 2

Perceived
Discriminati
on

Job
Strain

Caregiving
Stress

Social
Isolation

Neighborhood
stress

0.43

0.27

0.32

0.1

0.03

0.24

0.2

0.07

0.03

0.08

0.25

0.23

0.12

-0.001

0.24

0.07

-0.04
-0.11

0.01
0.03

Individuals
with total
score>=11
"Yes, very
upsetting"
"Yes, very
upsetting"

Individuals
with 4 or less
interpersonal
interactions
Individuals
residing in the
top 20% highly
disadvantaged
Neighborhoods
in
Pennsylvania

0.03

Alpha without
social isolation
Alpha Reliability
with social
isolation

0.55
0.49

** Social isolation was excluded due to negative impact on overall reliability
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Table A5.1: Agreement Statistics between Measures of Chronic Stress
Measure of Chronic Stress
Allostatic Load vs PSS-4
Allostatic Load vs Cumulative Chronic Stress score
PSS-4 vs Cumulative Chronic Stress score

Weighted Kappa*
0.016
0.11
0.2

95% C.I.
(-0.02, 0.052)
(0.07, 0.14)
(0.17, 0.24)

Spearman
Correlations**
0.03
0.16
0.30

* All measures of chronic stress are categorized into low, moderate, and high.
** Measures of chronic stress were assessed using their raw, uncategorized scores
PSS-4: Four-item Cohen’s Perceived Stress Scale

Table A5.2: Pearson Correlations with Measures of Chronic Stress against Optimism and Depressive symptoms
Measure of Chronic Stress**

Depressive
Symptoms

P-value

Optimism

P-value

Allostatic Load

0.06

0.006

-0.011

0.63

Cumulative Reported Chronic Stress

0.32

<.0001

-0.22

<.0001

PSS-4

0.53

<.0001

-0.49

<.0001

PSS-4: Four-item Cohen’s Perceived Stress Scale (PSS-4)
**All measures of chronic stress are categorized into low, moderate, and high.
N=1,800 for all pair-wise correlations
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Table A6: Incremental Predictive Performance of Measures of Chronic Stress
Model Parameters

Sample Size

"-2LLR"

AIC

C-statistic

Difference in 2LLR

Test of Difference

FRS

1825

1158.061

1160.061

0.7665

CRCS score (categorical)

1825

1204.47

1208.47

0.5231

AL

1825

1201.252

1203.252

0.578

Cohen PSS-4 (categorical)

1825

1204.031

1208.031

0.5363

FRS + CRCS Score categorical)

1825

1154.645

1160.645

0.7562

3.416

0.181227886

FRS + AL

1825

1157.84

1161.84

0.7697

0.221

0.638279023

FRS + PSS-4 (categorical)

1825

1155.993

1161.993

0.757

2.068

0.355581785

PCE

1825

1162.007

1164.007

0.7619

PCE+CRCS Score(categorical)

1825

1159.298

1165.298

0.7542

2.709

0.2580763

PCE + AL

1825

1161.79

1167.79

0.7647

0.217

0.641335337

PCE + PSS-4 (categorical)

1825

1160.078

1166.078

0.7529

1.929

0.381173739

FRS (Low Income Blacks)

205

111.097

113.097

0.6349

FRS (High Income Blacks)
FRS+CRCS Low Income
Blacks
FRS+CRCS Black High Income
Blacks

523

259.117

261.117

0.7441

205

106.152

112.152

0.7184

4.945

0.084373661

523

258.707

264.707

0.7285

0.41

0.814647316

FRS (Low Income Whites)

93

23.283

25.283

0.8775

FRS (High Income Whites)

837

413.05

415.05

0.7994

FRS+CRCS White Low income
FRS+CRCS High Income
Whites
FRS+PSS-4 Low Income
Whites

93

22.704

122.861

0.8307

0.579

0.748637793

837

406.883

412.883

0.7855

6.167

0.04579868

93

15.617

21.617

0.9249

PCE (LIB)

205

112.036

114.036

0.6247

301.014

PCE+CCS Score(LIB)

205

106.71

112.71

0.703

5.326

C-statistic
Bootstrapping

0.624
0.636

0.8789

0.8445

CRCS: Cumulative Reported Chronic Stressors; PSS: Perceived Stress Score
FRS: Framingham risk score ; PCE: Pooled Cohort Equation risk score
-2LLR: Negative two log-likelihood ratio test; AIC: Akaike information criterion
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0.069738692

Table A7.1: Net Reclassification Statistics Among Low-income Blacks using Framingham Risk Score (FRS) and Chronic Stress
Among low-income Blacks
without the event
(n=194)
FRS only
0 – <5%
5 – <10%
10 – <20%
>20%
Net reclassification

0 – <5%
87
19
2
0

5 – <10%
10 – <20%
60
0
15
7
0
3
0
0
-0.23

Among low-income Blacks
with the event
(n=11)
FRS + CRCS
>20%
0 – <5%
0
1
0
1
0
0
1
0

5 – <10% 10 – <20%
6
0
1
1
0
1
0
0
0.455

>20%
0
0
0
0

CRCS: Cumulative Reported Chronic Stressors

Table A7.2: Net Reclassification Statistics Among Low-income Blacks using Pooled Cohort Equation (PCE) Risk Score and Chronic Stress
Among low-income Blacks
without the event
(n=194)
PCE only
0 – <5%
5 – <10%
10 – <20%
>20%
Net reclassification

0 – <5%
79
26
1
0

5 – <10%
10 – <20%
58
0
19
8
0
3
0
0
-0.20

Among low-income Blacks
with the event
(n=11)
PCE + CRCS
>20%
0 – <5%
0
1
0
1
0
0
0
0

CRCS: Cumulative Reported Chronic Stressors
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5 – <10% 10 – <20%
6
0
2
1
0
0
0
0
0.545

>20%
0
0
0
0

Table A7.3: Net Reclassification Statistics Among High-Income Whites using Framingham Risk Score (FRS) and Chronic Stress
Among high-income Whites
Among high-income Whites
without the event
with the event
(n=801)
(n=36)
FRS + PSS-4
FRS only
0 – <5% 5 – <10%
10 – <20%
>20%
0 – <5% 5 – <10% 10 – <20% >20%
0 – <5%
681
17
0
0
15
2
0
0
5 – <10%
9
60
12
0
2
12
1
0
10 – <20%
2
0
13
6
0
0
3
0
>20%
0
0
0
1
1
0
0
0
Net reclassification
-0.03
0
PSS-4: Perceived Stress Score

Formula for Net Reclassification
NRI event = P(up|event)−P(down|event)
NRI non-event= P(down|nonevent)−P(up|nonevent)
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Table A8.1: Cox Proportional Hazards Regression of Measures of Chronic Stress with FRS against MACE
Variables
Number of events (events/total)
Cumulative Incidence
Framingham Risk Score
Categorized Chronic Stress
Low
Moderate
High
Categorized Allostatic Load
Low
Moderate
High
Three level PSS-4 Score
Low
Moderate
High

Model 1*
89/1825
4.88
1.05 (1.04,1.06)

Model 2
89/1825
4.88
1.05 (1.04, 1.06)

Model 3
89/1825
4.88
1.05 (1.04,1.06)

Model 4
89/1825
4.88
1.05 (1.04,1.06)

Referent
1.07 (0.68,1.68)
0.73 (0.38,1.39)

Referent
0.94 (0.59, 1.48)
0.56 (0.28, 1.09)

Referent
NA
NA

Referent
NA
NA

Referent
1.53 (0.93,2.53)
1.73 (0.98,3.06)

Referent
NA
NA

Referent
1.09 (0.65,1.82)
0.82 (0.44,1.53)

Referent
NA
NA

Referent
1.43 (0.86,2.38)
1.18 (0.71,1.95)

Referent
NA
NA

Referent
NA
NA

Referent
1.46 (0.88,2.44)
1.19 (0.72,1.99)

*Model 1 is the unadjusted model for all variables. NA: Variable was not in the model
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Table A8.2: Cox Proportional Hazards Regression of CRCS with FRS against MACE among Low Income Blacks (n=205)
Hazard Ratio (95% C.I.)
Variables

Model 1*

Model 2

Number of events (events/total)

11/205

11/205

Cumulative Incidence

5.37

5.37

Framingham Risk Score

1.03 (1.0, 1.07)

1.02 (0.99,1.06)

Low

Referent

Referent

Moderate

3.41 (0.43, 26.9)

3.06 (0.38,24.53)

High

0.5 (0.03, 7.84)

0.50 (0.03,8.03)

C-Statistic

0.6349, 0.6754

0.7184

Negative 2 Log Likelihood Ratio

111.097, 107.462

106.152

Categorized Chronic Stress Score

*Model 1 is the unadjusted model for both variables
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Table A8.3: Cox Proportional Hazards Regression of Measures of Chronic Stress and FRS against MACE defined using Stroke
Hazard Ratio (95% C.I.)
Variables
Number of events (events/total)
Cumulative Incidence
Framingham Risk Score
Categorized Chronic Stress Score
Low
Moderate
High
Three level PSS-4 Score
Low
Moderate
High
Categorized Allostatic Load
Low
Moderate
High

Model 1*
135/1825
7.4
1.05 (1.04,1.06)

Model 2
135/1825
7.4
1.05 (1.04,1.06)

Model 3
135/1825
7.4
1.05 (1.04,1.06)

Model 4
135/1825
7.4
1.05 (1.04,1.06)

Referent
0.93 (0.64,1.35)
0.67 (0.40,1.13)

Referent
0.93 (0.64,1.35)
0.67 (0.40,1.13)

Referent
NA
NA

Referent
NA
NA

Referent
1.35 (0.90,2.04)
1.05 (0.70,1.58)

Referent
NA
NA

Referent
NA
NA

Referent
1.44 (0.96,2.17)
1.17 (0.78,1.75)

Referent
1.83 (1.22,2.77)
2.05 (1.29,3.28)

Referent
NA
NA

Referent
1.35 (0.89,2.06)
1.12 (0.68,1.84)

Referent
NA
NA

*Model 1 is the unadjusted model for both variables. NA: Variable was not in the model
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Table A8.4: Cox Proportional Hazards Regression CRCS with FRS against MACE defined using Stroke among
Low Income Blacks (n=205)
Variables

Hazard Ratio (95% C.I.)
Model 1*

Model 2

Number of events (events/total)
Percentage of events
Framingham Risk Score
Categorized Chronic Stress Score
Low
Moderate
High

18/205
8.78
1.03 (1, 1.06)

18/205
8.78
1.02 (0.99,1.05)

Referent
1.79 (0.51, 6.23)
0.16 (0.02, 1.56)

Referent
1.62 (0.46,5.71)
0.17 (0.02,1.59)

C-Statistic
Negative 2 Log Likelihood Ratio

0.6443, 0.6859
181.636, 174.637

0.7318
172.641

*Model 1 is the unadjusted model for both variables

114

Table A9: Distribution of Baseline Characteristics by Race

N (%)
(n=1735)

Non-Hispanic
Whites
N (%)
(n=994)

Age (years) , Mean (SD)

58.9 ( 7.5)

59.6 ( 7.4)

58.1 ( 7.5)

0

Waist-hip ratio , Mean (SD)

0.9 ( 0.1)

0.9 ( 0.1)

0.9 ( 0.1)

0.76

Waist circumference (cm) , Mean (SD)

95.9 (15.2)

93.6 (14.2)

99.0 (15.9)

0

Body mass index , Mean (SD)

30.1 ( 6.4)

28.6 ( 5.8)

32.1 ( 6.5)

0

Total cholesterol , Mean (SD)

208 (41.6)

210 (40.9)

206 (42.3)

0.04

HDL cholesterol , Mean (SD)

55.8 (16.3)

55.1 (16.1)

56.6 (16.6)

0.06

Systolic BP , Mean (SD)

136 (19.9)

133 (18.8)

141 (20.4)

0

Diastolic BP , Mean (SD)

80.8 (10.2)

79.1 ( 9.9)

83.0 (10.2)

0

4.3 ( 3.0)

4.1 ( 2.9)

4.6 ( 3.2)

0

0.5 ( 0.7)

0.3 ( 0.6)

0.7 ( 0.7)

0

CESD score (>=16 items completed) ,
Mean (SD)

6.9 ( 7.9)

6.4 ( 7.4)

7.5 ( 8.5)

0

LOT score (optimism) , Mean (SD)

17.1 ( 4.0)

17.1 ( 4.1)

17.2 ( 4.0)

0.45

Male

580 (33.4)

362 (36.4)

218 (29.4)

Female

1155 (66.6)

632 (63.6)

523 (70.6)

Total
Subject Characteristics

Cohen stress score , Mean (SD)
Cumulative chronic stress score without
social isolation , Mean (SD)

Non-Hispanic Blacks
N (%)
(n=741)

Gender

P-value

0
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Table A9 (Continued)
Age (years)

0

45 to 55

631 (36.4)

314 (31.6)

317 (42.8)

56 to 65

720 (41.5)

443 (44.6)

277 (37.4)

66 to 74

384 (22.1)

237 (23.8)

147 (19.8)

Annual income
Less than $10,000

0
95 (6.1)

29 (3.3)

66 (9.7)

$10K to < $20K

187 (11.9)

61 (6.8)

126 (18.6)

$20K to < $40K

447 (28.5)

225 (25.3)

222 (32.7)

$40K to < $80K

521 (33.2)

307 (34.5)

214 (31.5)

$80,000 or more

320 (20.4)

269 (30.2)

51 (7.5)

Financial stress

0

No

1558 (90.0)

921 (92.8)

637 (86.1)

Yes

174 (10.0)

71 (7.2)

103 (13.9)

Discrimination-related stress

0

No

1193 (70.3)

794 (80.9)

399 (55.7)

Yes

504 (29.7)

187 (19.1)

317 (44.3)

Caregiving stress
No

0.09
1630 (96.8)

943 (97.4)
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687 (95.9)

Table A9 (Continued)
Yes

54 (3.2)

25 (2.6)

29 (4.1)

Job-related strain

0.13

No

1638 (96.0)

947 (96.6)

691 (95.2)

Yes

68 (4.0)

33 (3.4)

35 (4.8)

Primary insurance
Medicare
Medicaid/Other public
Private
None/self-pay

0
246 (14.2)

138 (13.9)

108 (14.6)

51 (2.9)

12 (1.2)

39 (5.3)

1326 (76.7)

808 (81.5)

518 (70.2)

106 (6.1)

33 (3.3)

73 (9.9)

Education

0

Less than HS

34 (2.0)

12 (1.2)

22 (3.0)

HS diploma

293 (16.9)

154 (15.5)

139 (18.8)

Some college

561 (32.4)

244 (24.6)

317 (42.8)

Bachelor’s degree

390 (22.5)

251 (25.3)

139 (18.8)

Advanced degree

453 (26.2)

330 (33.3)

123 (16.6)

Work status past 3 mo.
Full-time

0
783 (45.3)

432 (43.6)
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351 (47.5)

Table A9 (Continued)
Part-time

254 (14.7)

178 (18.0)

76 (10.3)

Retired

472 (27.3)

273 (27.6)

199 (26.9)

Other

220 (12.7)

107 (10.8)

113 (15.3)

QOL: Health

0

Excellent

284 (16.5)

209 (21.2)

75 (10.2)

Very good

632 (36.6)

430 (43.5)

202 (27.4)

Good

606 (35.1)

293 (29.7)

313 (42.5)

Fair

186 (10.8)

51 (5.2)

135 (18.3)

Poor

17 (1.0)

5 (0.5)

12 (1.6)

Current smoker

0

No

1548 (89.4)

910 (91.7)

638 (86.3)

Yes

183 (10.6)

82 (8.3)

101 (13.7)

Framingham risk strata at baseline

0

Low risk

976 (57.1)

606 (61.7)

370 (51.0)

Intermediate risk

416 (24.4)

242 (24.6)

174 (24.0)

High risk

316 (18.5)

134 (13.6)

182 (25.1)

History of hypertension

0

No

1021 (58.9)

692 (69.8)

329 (44.5)

Yes

711 (41.1)

300 (30.2)

411 (55.5)
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Table A10: Stratified Analyses of Demographic Characteristics Comparing Incidence of MACE in Non-Hispanic Blacks to Non-Hispanic Whites
Black

Overall
Age
45 to 55
56 to 65
66 to 74
Gender
Female
Male
Income
$20,000 or less
$20,001 to $80,000
$80,000 or more

White

Events
38

PY
7495

IR
5.07

Events/N
49/994

Events
49

PY
10226

IR
4.79

IRR
(95% C.I.)
1.04 (0.68, 1.59)

Pvalue
0.855

13/317
12/277
13/147

13
12
13

3276.2
2820.2
1399.5

3.97
4.26
9.29

3/314
25/443
21/237

3
25
21

3275.6
4527.6
2422.9

0.92
5.52
8.67

4.29 (1.22,
15.06)
0.77 (0.38, 1.53)
0.99 (0.49, 1.99)

0.023
0.452
0.996

18/523
20/218

18
20

5271.5
2224.39

3.41
8.99

20/632
29/362

20
29

6569.8
3656.4

3.04
7.93

1.09 (0.57, 2.06)
1.14 (0.65, 2.02)

0.796
0.641

11/192
23/436
1/51

11
23
1

1962.2
4334.8
548.5

5.61
5.31
1.82

3/90
23/532
12/269

3
23
12

920.4
5591.3
2660.3

3.26
4.11
4.51

1.72 (0.48, 6.16)
1.22 (0.69, 2.18)
0.44 (0.06, 3.38)

0.406
0.5
0.43

Events/N
38/741

PY: Person-years; IR: Incidence rate per 1,000 PY; IRR: Incidence Rate Ratios; CI: 95% Confidence Intervals; MACE: Major Cardiac Adverse Events
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Table A11.1: Distribution of Components of MACE by Race

Characteristics

White

Race
Total

Black

P-value

Cause
Myocardial Infarction
9 (18.4)
8 (21.1)
17 (19.5)
Revascularization
29 (59.2)
17 (44.7)
46 (52.9)
Cardiac Death
11 (22.4)
13 (34.2)
24 (27.6)
P-values are from a Chi-square test for categorical variables

0.3684

MACE: Major Cardiac Adverse Events

Table A11.2: Association between Components of Cumulative Reported Chronic Stressors by Components of MACE

Caregiving
stress
Characteristics
Cause
No event
Myocardial
Infarction

No

Yes

1546
(94.9)

54
(100)

Job-related
strain
Pvalue
0.4027

16 (1)
0
44
Revascularization (2.7)
0
24
Cardiac death
(1.5)
0
P-values are from a Chi-square test for
categorical variables

No

Yes

1554
(94.9)
15
(0.9)
45
(2.8)
24
(1.5)

66
(97.1)
1
(1.5)
1
(1.5)
0

Financial
Stress
Pvalue
0.6508

No

Yes

1477
(94.8)

168
(96.6)
2
(1.2)
4
(2.3)

15 (1)
42
(2.7)
24
(1.5)

MACE: Major Cardiac Adverse Events
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0

Neighborhood
Deprivation
within PA

Discriminationrelated stress
Pvalue
0.4106

No

Yes

1136
(95.2)
11
(0.9)
36 (3)
10
(0.8)

Pvalue
0.0124

No

Yes

475
(94.3)

1005
(94.6)

442
(95.5)

5 (1)

10 (0.9)

5 (1.1)

10 (2)
14
(2.8)

32 (3)

9 (1.9)

15 (1.4)

7 (1.5)

Pvalue
0.687

Table A12.1: Total and Controlled Direct Effects of Race on MACE with Chronic Stress as a Mediator
Before controlling for traditional risk factors of CHD
Study Measures

Sample
size

Total Effect
(95% C.I)

Sample
Size

CRCS

1,443

1.79 (1.05 , 3.05)

CRCS (without n/hood
deprivation)
CRCS (with imputation)

1,443

Individual components of
CRCS
Financial difficulty

After controlling for traditional risk factors of CHD
Percent
Eliminated
(%)
43

Sample
Size

Total Effect
(95% C.I)

Sample
Size

1,443

Controlled
Direct Effect
(95% C.I.)
1.45 (0.70 , 3.01)

1,378

Controlled
Direct Effect
(95% C.I.)
1.39 (0.64, 3)

Percent
Eliminated
(%)
12.6

1,378

1.44 (0.83 , 2.51)

1.79 (1.05 , 3.05)

1,443

1.59 (0.83 , 3.07)

34

1,378

1.44 (0.83, 2.51

1,378

1.48 (0.73, 2.98)

-7.7

1,735

1.25 (0.78, 2.02)

1,735

1.03 (0.52, 2.01)

88

1,735

1.02 (0.62, 1.67)

_

NA

NA

1,443

1.79 (1.05 , 3.05)

1,443

1.89 (1.12 , 3.19)

-12.8

1,378

1.44 (0.83 , 2.51)

1,378

1.69 (0.96, 2.95)

-54.9

Discrimination

1,443

1.79 (1.05 , 3.05)

1,424

1.37 (0.74 , 2.56)

52.8

1,378

1.44 (0.83 , 2.51)

1,359

0.90 (0.49, 1.68)

121.7

Caregiving

1,443

1.79 (1.05 , 3.05)

1,410

1.71 (1.03 , 2.85)

10.3

1,378

1.44 (0.83 , 2.51)

1,346

1.10 (0.66, 1.85)

76.7

Job stress

1,443

1.79 (1.05 , 3.05)

1,428

1.52 (0.91 , 2.55)

34.2

1,378

1.44 (0.83 , 2.51)

1,363

1.01 (0.60, 1.71)

97.7

Deprivation

1,443

1.79 (1.05 , 3.05)

1,270

2.17 (1.22 , 3.86)

-48.1

1,378

1.44 (0.83 , 2.51)

1,215

1.55 (0.86, 2.78)

-24.2

1,443

1.79 (1.05 , 3.05)

1,441

1.94 (0.82, 4.56)

-19

1,378

1.44 (0.83 , 2.51)

1,376

1.75 (0.72, 4.29)

-69.7

PSS

** The estimates for job stress and caregiving stress are unstable due to sparse data or near zero cells
CRCS: Cumulative Reported Chronic Stressors; PSS: Perceived Stress Score
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Table A12.2: Variables used in Multiple Imputation Analysis
Variable
% missing Impute
d
Age
0
No
Sex
0
No
Race
0
No
Systolic Blood Pressure
0
No
Education
0.23
Yes
Employment status
0.35
Yes
Insurance status
0.35
Yes
Renal disease
0.46
Yes
Self-rated quality of life (QoL)
0.58
Yes
Cohen PSS
CESD
Family hx of premature CAD
Income

0.98
1.1
6.92
9.51

Yes
Yes
Yes
Yes

Imputation model
NA
NA
NA
NA
Age, Sex, and Race
Age, Sex, Race, and imputed Education
Age, Sex, Race, imputed Education, and imputed employment status
Age, Sex, Race, and systolic blood pressure
Age, Sex, Race, imputed Education, imputed employment status, and imputed
insurance
Age, Sex, Race, and imputed QoL
Age, Sex, Race, imputed QoL, and imputed Cohen PSS
Age, Sex, Race, and systolic blood pressure
Age, Sex, Race, imputed Education, imputed employment status, imputed
insurance, and imputed QoL
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Table A13: Derivation of the Ideal Cardiovascular Health (ICH) Score
Life Simple 7 (LS7) Component
BMI (kg/m^2)
Smoking
Physical Activity
Nutrition (based on daily consumption
of fruits and vegetables, only)

Poor (0)
>=30
Current smoker
Mild or sedentary
<2

Intermediate (1)
25 - <30
Past smoker
Moderate
2 - <=4

Ideal (2)
<25
Never smoked
Strenuous
>=4

Cholesterol

>=240

200 - <240
or <200 and on treatment

<200 and no treatment

Systolic and diastolic blood pressure

>=140 or >=90

<120 and <80 and treated or systolic BP
>=120 and <140 or diastolic BP >=80 and
<90

Fasting Blood Glucose

>=126

100 to 126 or <100 with treatment

<120 and <80 without
treatment
<100 and without treatment

Total possible score
Final ICH group

0
<=4

7
5 to 9

14
10 or higher

123

Table A14: Distribution of Baseline Characteristics by Chronic Stress
_______________________________________________________________________________________________
No Chronic High Chronic
Total
Stress
Stress
N (%)
N (%)
N (%)
Subject Characteristics
(n=1380)
(n=669)
(n=711)
P-value
Age (years) , Mean (SD)
58.7 ( 7.4)
59.9 ( 7.3)
57.6 ( 7.3)
0.00
Cohen stress score , Mean (SD)

4.3 ( 3.0)

3.5 ( 2.4)

5.2 ( 3.3)

0.00

Waist circumference (cm) , Mean (SD)

95.9 (14.9)

94.4 (14.0)

97.3 (15.4)

0.00

Body mass index , Mean (SD)

30.1 ( 6.3)

29.1 ( 6.0)

31.1 ( 6.4)

0.00

Systolic BP , Mean (SD)

136 (19.5)

135 (18.2)

138 (20.5)

0.00

Total cholesterol (mg/dL) , Mean (SD)

208 (41.1)

208 (38.2)

208 (43.7)

0.76

LDL cholesterol (mg/dL) , Mean (SD)

143 (36.4)

144 (33.9)

142 (38.6)

0.34

Triglycerides (mg/dL) , Mean (SD)

122 (75.9)

123 (72.2)

121 (79.3)

0.65

VLDL cholesterol (mg/dL) , Mean (SD)

13.3 ( 9.4)

13.6 ( 8.9)

13.0 ( 9.8)

0.18

ICH Score , Mean (SD)

7.1 ( 2.2)

7.5 ( 2.2)

6.7 ( 2.1)

0.00

CESD score (>=16 items completed) , Mean (SD)

6.9 ( 7.9)

4.5 ( 5.0)

9.2 ( 9.4)

0.00

Cholesterol (mg) , Mean (SD)

124 (97.0)

116 (83.8)

131 ( 108)

0.00

Total dietary monounsaturated fat (gm) , Mean (SD)

8.6 ( 4.7)

8.4 ( 4.4)

8.9 ( 5.0)

0.06

Total dietary polyunsaturated fat (gm) , Mean (SD)

2.3 ( 1.0)

2.2 ( 0.9)

2.3 ( 1.1)

0.05

Total dietary saturated fat (gm) , Mean (SD)

9.1 ( 4.9)

8.9 ( 4.6)

9.2 ( 5.1)

0.30
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Table A14 (Continued)
_______________________________________________________________________________________________
Total dietary fat (gm) , Mean (SD)

22.5 (11.6)

22.0 (10.8)

23.0 (12.3)

0.11

1.3 ( 0.7)

1.3 ( 0.7)

1.3 ( 0.8)

0.80

Dietary protein (gm) , Mean (SD)

32.8 (16.6)

32.5 (15.2)

33.1 (17.8)

0.56

Dietary sodium (mg) , Mean (SD)

459 ( 218)

453 ( 199)

465 ( 234)

0.34

Gender
Male
Female

478 (34.6)
902 (65.4)

257 (38.4)
412 (61.6)

221 (31.1)
490 (68.9)

Race
White
Black

783 (56.7)
597 (43.3)

533 (79.7)
136 (20.3)

250 (35.2)
461 (64.8)

Annual income
Less than $10,000
$10K to < $20K
$20K to < $40K
$40K to < $80K
$80,000 or more

76 (5.5)
167 (12.1)
396 (28.7)
468 (33.9)
273 (19.8)

16 (2.4)
53 (7.9)
163 (24.4)
234 (35.0)
203 (30.3)

60 (8.4)
114 (16.0)
233 (32.8)
234 (32.9)
70 (9.8)

Education attainment
At least High School
Some college
Bachelor's or Advanced degree

247 (17.9)
452 (32.8)
681 (49.3)

106 (15.8)
158 (23.6)
405 (60.5)

141 (19.8)
294 (41.4)
276 (38.8)

Current smoker
No
Yes

1230 (89.3)
147 (10.7)

625 (93.6)
43 (6.4)

605 (85.3)
104 (14.7)

Trans dietary fats (gm) , Mean (SD)

0.00

0.00

0.00

0.00

0.00

History of diabetes

0.00
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Table A14 (Continued)
_______________________________________________________________________________________________
No
1247 (90.7)
624 (93.6)
623 (88.0)
Yes
128 (9.3)
43 (6.4)
85 (12.0)
ICH score in 3 categories
Poor
Intermediate
Ideal

0.00
160 (11.6)
1021 (74.1)
197 (14.3)

55 (8.2)
491 (73.4)
123 (18.4)

105 (14.8)
530 (74.8)
74 (10.4)

Eat stanol or sterol products
Less than once per week
Once per week
2-4 times per week
Nearly daily or daily

394 (74.5)
26 (4.9)
58 (11.0)
46 (8.7)

205 (71.9)
11 (3.9)
39 (13.7)
28 (9.8)

189 (77.5)
15 (6.1)
19 (7.8)
18 (7.4)

0.12
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Table A15: Metabolites Associated with Cumulative Chronic Stressors and Perceived Stress
BIOCHEMICAL
Tetradecanedioate (C14-DC)
Glycosyl-N-palmitoyl-sphingosine
(d18:1/16:0)
Retinol (Vitamin A)
Creatine
5-dodecenoylcarnitine (C12:1)
1-linoleoyl-GPI (18:2)*
4-hydroxyhippurate
N1-Methyl-2-pyridone-5-carboxamide
Trigonelline (N'-methylnicotinate)
3,7-dimethylurate
Methyl-4-hydroxybenzoate sulfate
Glucuronide of C10H18O2 (7)*
Umbelliferone sulfate
Cholate
Docosahexaenoylcholine
Docosahexaenoylcarnitine (C22:6)*
4-ethylphenylsulfate
Propyl 4-hydroxybenzoate sulfate
7-methylxanthine
Oleoyl-oleoyl-glycerol (18:1/18:1) [2]*
3-methylhistidine
Beta-cryptoxanthin
Docosadioate (C22-DC)
Androstenediol (3alpha, 17alpha)
monosulfate (3)
3-hydroxy-2-ethylpropionate
Laurate (12:0)
Hexadecanedioate (C16-DC)

SUPER_PATHWAY
Lipid

SUB_PATHWAY
Fatty Acid, Dicarboxylate

Odds Ratio {95%
CI}
[ 2.28 {1.52-3.42} ]

Lipid
Cofactors and Vitamins
Amino Acid
Lipid
Lipid
Xenobiotics
Cofactors and Vitamins
Cofactors and Vitamins
Xenobiotics
Xenobiotics
Partially Characterized
Molecules
Xenobiotics
Lipid
Lipid
Lipid
Xenobiotics
Xenobiotics
Xenobiotics
Lipid
Amino Acid
Cofactors and Vitamins
Lipid

Ceramides
Vitamin A Metabolism
Creatine Metabolism
Fatty Acid Metabolism(Acyl Carnitine)
Lysophospholipid
Benzoate Metabolism
Nicotinate and Nicotinamide Metabolism
Nicotinate and Nicotinamide Metabolism
Xanthine Metabolism
Benzoate Metabolism

[ 1.93 {1.14-3.28} ]
[ 1.75 {1.03-2.95} ]
[ 1.62 {1.13-2.31} ]
[ 1.5 {1.11-2.03} ]
[ 1.45 {1.01-2.08} ]
[ 1.35 {1.12-1.62} ]
[ 1.33 {1.01-1.75} ]
[ 1.17 {1.02-1.35} ]
[ 1.17 {1.01-1.35} ]
[ 1.15 {1.01-1.3} ]

Partially Characterized Molecules
Food Component/Plant
Primary Bile Acid Metabolism
Fatty Acid Metabolism (Acyl Choline)
Fatty Acid Metabolism(Acyl Carnitine)
Benzoate Metabolism
Benzoate Metabolism
Xanthine Metabolism
Diacylglycerol
Histidine Metabolism
Vitamin A Metabolism
Fatty Acid, Dicarboxylate

[ 1.1 {1-1.21} ]
[ 0.92 {0.84-0.99} ]
[ 0.91 {0.83-0.99} ]
[ 0.87 {0.78-0.97} ]
[ 0.86 {0.76-0.99} ]
[ 0.86 {0.77-0.96} ]
[ 0.85 {0.77-0.93} ]
[ 0.84 {0.72-0.98} ]
[ 0.82 {0.7-0.95} ]
[ 0.78 {0.7-0.87} ]
[ 0.72 {0.6-0.86} ]
[ 0.71 {0.56-0.91} ]

Lipid
Amino Acid
Lipid
Lipid

Androgenic Steroids
Leucine, Isoleucine and Valine Metabolism
Medium Chain Fatty Acid
Fatty Acid, Dicarboxylate

[ 0.68 {0.56-0.84} ]
[ 0.64 {0.41-0.99} ]
[ 0.56 {0.4-0.78} ]
[ 0.55 {0.35-0.85} ]
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Table A15 (Continued)
Caproate (6:0)

Lipid

Medium Chain Fatty Acid

[ 0.53 {0.39-0.73} ]

BIOCHEMICAL
Sphingomyelin (d18:1/18:1, d18:2/18:0)
2-hydroxybehenate
Phenol glucuronide
Ectoine
Bilirubin (Z,Z)
Heptanoate (7:0)

SUPER_PATHWAY
Lipid
Lipid
Amino Acid
Xenobiotics
Cofactors and Vitamins
Lipid

β(SE); P-value
1 (0.35); 0.004
0.55 (0.22); 0.013
-0.12 (0.05); 0.02
-0.15 (0.06); 0.015
-0.19 (0.09); 0.03
-0.23 (0.08); 0.004

3-aminoisobutyrate
Sphingomyelin (d18:1/25:0, d19:0/24:1,
d20:1/23:0, d19:1/24:0)*

Nucleotide

SUB_PATHWAY
Sphingolipid Metabolism
Fatty Acid, Monohydroxy
Tyrosine Metabolism
Chemical
Hemoglobin and Porphyrin Metabolism
Medium Chain Fatty Acid
Pyrimidine Metabolism, Thymine
containing

Lipid

Sphingolipid Metabolism

-0.44 (0.2); 0.03

-0.39 (0.15); 0.01

Odds Ratios represent effect size for metabolites associated with the Cumulative Reported Chronic Stress (CRCS) while β(SE) represent effects for metabolites associated with perceived stress
CI: confidence interval; PSS: perceived stress score; CRCS: cumulative chronic stress score
* The metabolite has not been confirmed based on a standard but there is high confidence in its identity
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Table A16: Metabolites with the Largest Correlation Coefficients with Principal Components Associated with Chronic Stress
BIOCHEMICAL
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)
docosahexaenoate (DHA; 22:6n3)
docosahexaenoylcarnitine (C22:6)*
eicosapentaenoate (EPA; 20:5n3)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)*
hydroxy-CMPF*
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*
1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6)
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*
2-hydroxyarachidate*
2-hydroxybehenate
2-hydroxynervonate*
N-acetylhistidine

SUPER_PATHWAY
Lipid
Lipid
Lipid
Lipid
Lipid
Xenobiotics
Lipid
Lipid
Lipid
Lipid
Lipid
Lipid
Lipid
Amino Acid

* The metabolite has not been confirmed based on a standard but there is high confidence in its identity
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SUB_PATHWAY
Fatty Acid, Dicarboxylate
Polyunsaturated Fatty Acid (n3 and n6)
Fatty Acid Metabolism(Acyl Carnitine)
Polyunsaturated Fatty Acid (n3 and n6)
Phosphatidylcholine (PC)
Chemical
Phosphatidylcholine (PC)
Phosphatidylethanolamine (PE)
Phosphatidylcholine (PC)
Phosphatidylethanolamine (PE)
Fatty Acid, Monohydroxy
Fatty Acid, Monohydroxy
Fatty Acid, Monohydroxy
Histidine Metabolism

Table A17: Ordinal Regression Showing Relationship of Stress-related Metabolites and Ideal Cardiovascular Health (ICH) Overall and by
Race
Variables
Age
Sex
Female
Male
Education
Bachelor's or Advanced degree
At least High School
Some college
Income
$80,000 or more
$10K to < $20K
$20K to < $40K
$40K to < $80K
Less than $10,000
Race
White
Black
7-methylxanthine
beta-cryptoxanthin
laurate (12:0)
tetradecanedioate (C14-DC)
androstenediol (3alpha, 17alpha)
monosulfate (3)
methyl-4-hydroxybenzoate
sulfate
oleoyl-oleoyl-glycerol (18:1/18:1)
[2]*
3,7-dimethylurate
retinol (Vitamin A)

ICH score in 3 categories
(n=1378)
1.02 (1.00-1.04)

ICH score in 3 categories: Whites
(n=783)
1.04 (1.02-1.07)

ICH score in 3 categories: Blacks
(n=595)
1.00 (0.97-1.03)

Referent
1.10 (0.76-1.61)

Referent
1.36 (0.81-2.29)

Referent
0.90 (0.51-1.58)

Referent
1.12 (0.76-1.64)
1.25 (0.92-1.70)

Referent
1.38 (0.82-2.31)
1.12 (0.74-1.71)

Referent
0.76 (0.41-1.41)
1.25 (0.78-1.99)

Referent
1.20 (0.72-2.01)
1.45 (0.97-2.16)
1.24 (0.86-1.78)
1.50 (0.79-2.86)

Referent
1.09 (0.51-2.34)
1.40 (0.86-2.28)
1.34 (0.88-2.06)
1.87 (0.66-5.30)

Referent
1.06 (0.42-2.70)
1.28 (0.55-2.98)
0.90 (0.40-2.07)
1.32 (0.47-3.76)

Referent
3.21 (2.23-4.60)
0.83 (0.73-0.96)
0.41 (0.34-0.48)
1.49 (1.10-2.02)
0.70 (0.57-0.87)

Referent
NA
0.77 (0.63-0.94)
0.37 (0.30-0.47)
2.54 (1.63-3.95)
0.62 (0.45-0.84)

Referent
NA
0.90 (0.74-1.10)
0.44 (0.34-0.59)
0.86 (0.56-1.34)
0.80 (0.58-1.10)

1.22 (1.01-1.47)

1.34 (1.03-1.74)

1.09 (0.82-1.45)

0.88 (0.80-0.96)

0.89 (0.79-0.99)

0.88 (0.76-1.02)

1.24 (1.09-1.41)
1.20 (1.05-1.37)
2.39 (1.50-3.81)

1.32 (1.10-1.59)
1.31 (1.08-1.57)
2.98 (1.51-5.86)

1.17 (0.97-1.42)
1.07 (0.88-1.30)
2.03 (1.04-3.98)

130

Table A17 (Continued)

caproate (6:0)
sphingomyelin (d18:1/18:1,
d18:2/18:0)
3-aminoisobutyrate
sphingomyelin (d18:1/25:0,
d19:0/24:1, d20:1/23:0,
d19:1/24:0)*
2-hydroxybehenate

0.67 (0.50-0.90)

0.71 (0.49-1.04)

0.54 (0.33-0.89)

3.34 (1.88-5.96)
0.57 (0.44-0.74)

4.84 (2.12-11.06)
0.38 (0.24-0.60)

2.42 (1.04-5.62)
0.73 (0.53-1.00)

1.84 (1.31-2.58)
1.65 (1.15-2.37)

1.99 (1.26-3.13)
1.72 (1.06-2.80)

1.64 (0.97-2.79)
1.70 (0.97-2.97)

* The metabolite has not been confirmed based on a standard but there is high confidence in its identity
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Table A18: Ordinal Regression of Stress-related Metabolites and Components of Ideal Cardiovascular Health (ICH)
ICH BP
(n=1380)
0.81 (0.66-0.99)

ICH BMI
(n=1371)
0.66 (0.54-0.82)

ICH SMOKE
(n=1374)
NA

ICH
CHOLESTEROL
(n=1378)
0.75 (0.61-0.92)

beta-cryptoxanthin
Retinol (Vitamin A)
sphingomyelin
(d18:1/18:1,
d18:2/18:0)
sphingomyelin
(d18:1/25:0,
d19:0/24:1,
d20:1/23:0,
d19:1/24:0)

0.74 (0.66-0.83)
1.77 (1.22-2.55)

0.50 (0.43-0.57)
0.63 (0.43-0.93)

0.69 (0.61-0.78)
1.49 (1.02-2.17)

1.14 (1.00-1.30)
3.43 (2.30-5.12)

ICH Diet
(n=1371)
NA
0.48 (0.420.55)
NA

NA

4.22 (2.60-6.85)

0.42 (0.27-0.66)

4.70 (2.91-7.61)

1.84 (1.192.84)

NA

1.60 (1.20-2.11)

NA

2.62 (1.97-3.47)

laurate (12:0)
7-methylxanthine
tetradecanedioate
(C14-DC)
3,7-dimethylurate

NA
NA

1.33 (1.03-1.72)
0.80 (0.71-0.91)

NA
NA

NA
NA

NA
NA

0.73 (0.60-0.87)
1.32 (1.18-1.48)

0.71 (0.61-0.84)
NA

NA
NA

caproate (6:0)
methyl-4hydroxybenzoate
sulfate
2-hydroxybehenate
oleoyl-oleoylglycerol (18:1/18:1)
[2]*

NA

0.43 (0.33-0.55)

NA

NA
NA

0.87 (0.81-0.94)
NA

NA

NA

Variables
3-aminoisobutyrate

ICH PA
(n=1370)
0.75 (0.61-0.93)

ICH
GLUCOSE
(n=1370)
0.65 (0.52-0.82)

0.72 (0.63-0.81)
NA

0.72 (0.63-0.83)
NA

2.32 (1.46-3.69)

NA

NA
1.32 (1.061.65)
NA

NA

NA

NA
NA

NA
0.77 (0.68-0.87)

NA
NA

NA
1.21 (1.08-1.37)

1.42 (1.11-1.82)

NA
NA
0.68 (0.540.87)

NA

0.62 (0.48-0.82)

NA
1.41 (1.05-1.90)

0.92 (0.86-0.99)
1.93 (1.43-2.60)

NA
NA

NA
NA

0.92 (0.85-0.99)
1.78 (1.29-2.47)

1.13 (1.01-1.27)

1.15 (1.03-1.28)

NA

NA

1.20 (1.05-1.36)

PA: Physical activity; BMI: Body Mass Index; BP: Blood Pressure; NA: Variable not in the model
* The metabolite has not been confirmed based on a standard but there is high confidence in its identity
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Table A19: Cox Proportional Hazards Regression of Beta-Cryptoxanthin and Incident MACE
Variables
Beta-Cryptoxanthin
Age (years)
Gender
Female
Male
Education attainment
Bachelor's or Advanced
degree
At least High School
Some college
Annual income
$80,000 or more
$10K to < $20K
$20K to < $40K
$40K to < $80K
Less than $10,000
Race
White
Black
Systolic BP
Total cholesterol
Current smoker
No
Yes
NA= Variable not in model

Model 1
(n=1380)
0.77 (0.61,0.97)
NA

Model 2
(n=1380)
0.75 (0.59,0.95)
1.06 (1.02,1.10)

Model 3
(n=1377)
0.75 (0.59,0.97)
1.05 (1.02,1.10)

Model 4 (Whites)
(n=783)
0.60 (0.45,0.80)
1.09 (1.03,1.15)

Model 5 (Blacks)
(n=597)
1.01 (0.63,1.62)
1.04 (0.99,1.10)

Referent
3.40 (2.01,5.74)

Referent
3.22 (1.86,5.58)

Referent
4.28 (1.82,10.05)

Referent
2.87 (1.39,5.95)

Referent
2.03 (1.02,4.02)
1.44 (0.74,2.80)

Referent
2.04 (1.03,4.05)
1.38 (0.71,2.70)

Referent
2.73 (1.06,7.08)
2.00 (0.75,5.33)

Referent
1.34 (0.50,3.56)
1.04 (0.43,2.55)

Referent
0.68 (0.24, 1.94)
0.77 (0.33, 1.78)
1.05 (0.49, 2.22)
0.93 (0.27, 3.16)

Referent
0.66 (0.23, 1.87)
0.74 (0.32, 1.73)
1.05 (0.49, 2.22)
0.92 (0.27, 3.15)

Referent
0.51 (0.1, 2.67)
0.47 (0.16, 1.38)
0.59 (0.23, 1.5)
1.01 (0.12, 8.55)

Referent
2.14 (0.23, 20.24)
2.45 (0.29, 21.04)
2.94 (0.37, 23.68)
2.65 (0.25, 28.07)

Referent
1.84 (1.07,3.17)
NA
NA

Referent
1.68 (0.96,2.93)
1.01 (1.00,1.03)
1.00 (1.00,1.01)

Referent
NA
1 (0.98, 1.02)
1 (0.99, 1.01)

Referent
NA
1.02 (1, 1.04)
1 (0.99, 1.01)

Referent
NA

Referent
1.22 (0.57,2.64)

Referent
1.25 (0.38, 4.07)

Referent
1.39 (0.49, 3.92)
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The exact data fields to be requested and used in the analysis are as follows:
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State (state of residence of participant)
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University of South Florida / 3702 Spectrum Blvd., Suite 165 / Tampa, FL 33612 / 813974-5638
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